<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006880" GROUP_ID="LIVER" ID="068006091811582714" MERGED_FROM="" MODIFIED="2008-11-12 11:26:37 +0100" MODIFIED_BY="dimitrinka nikolova" NOTES="&lt;p&gt;Exported from Review Manager 4.2.9&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.9&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-11-12 11:26:37 +0100" NOTES_MODIFIED_BY="dimitrinka nikolova" REVIEW_NO="15" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="2.4">
<COVER_SHEET MODIFIED="2008-11-12 11:19:27 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<TITLE>Techniques for liver parenchymal transection in liver resection</TITLE>
<CONTACT>
<PERSON ID="EDD1B9F582E26AA20135ECF1AB0B3200" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Kurinchi Selvan</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Gurusamy</LAST_NAME>
<SUFFIX>MBBS MS MRCS</SUFFIX>
<POSITION>Research Fellow</POSITION>
<EMAIL_1>kurinchi2k@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>+44 (0)7944 629303</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>University Department of Surgery</DEPARTMENT>
<ORGANISATION>Royal Free Hospital and University College School of Medicine</ORGANISATION>
<ADDRESS_1>9th Floor, Royal Free Hospital</ADDRESS_1>
<ADDRESS_2>Pond Street</ADDRESS_2>
<CITY>London</CITY>
<ZIP>NW3 2QG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 207 830 2757</PHONE_1>
<PHONE_2/>
<FAX_1>+44 207 830 2688</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2008-11-12 11:19:27 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<PERSON ID="EDD1B9F582E26AA20135ECF1AB0B3200" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Kurinchi Selvan</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Gurusamy</LAST_NAME>
<SUFFIX>MBBS MS MRCS</SUFFIX>
<POSITION>Research Fellow</POSITION>
<EMAIL_1>kurinchi2k@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>+44 (0)7944 629303</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>University Department of Surgery</DEPARTMENT>
<ORGANISATION>Royal Free Hospital and University College School of Medicine</ORGANISATION>
<ADDRESS_1>9th Floor, Royal Free Hospital</ADDRESS_1>
<ADDRESS_2>Pond Street</ADDRESS_2>
<CITY>London</CITY>
<ZIP>NW3 2QG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 207 830 2757</PHONE_1>
<PHONE_2/>
<FAX_1>+44 207 830 2688</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="7B45313A82E26AA20071EDC0B3411103" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Viniyendra</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Pamecha</LAST_NAME>
<SUFFIX>MRCS</SUFFIX>
<POSITION>Senior Clinical Fellow</POSITION>
<EMAIL_1>viniyendra@yahoo.co.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>University Department of Surgery</DEPARTMENT>
<ORGANISATION>Royal Free Hospital and University College School of Medicine</ORGANISATION>
<ADDRESS_1>42, Allendale close</ADDRESS_1>
<ADDRESS_2>Camberwell Green</ADDRESS_2>
<CITY>London</CITY>
<ZIP>SE5 8SG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 7792529207</PHONE_1>
<PHONE_2>+44 207 703 0414</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="7B452FB382E26AA20071EDC0DF8733F6" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Dinesh</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Sharma</LAST_NAME>
<SUFFIX>FRCS</SUFFIX>
<POSITION>Consultant Hepatobiliary Surgeon</POSITION>
<EMAIL_1>Dinesh.Sharma@royalfree.nhs.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>University Department of Surgery</DEPARTMENT>
<ORGANISATION>Royal Free Hospital and University College School of Medicine</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP>NW3 2QG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 207 794 0500 ext: 3934</PHONE_1>
<PHONE_2/>
<FAX_1>+44 207 472 6711</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="0BFE5DB682E26AA200426E053932D8DE" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Brian</FIRST_NAME>
<MIDDLE_INITIALS>R</MIDDLE_INITIALS>
<LAST_NAME>Davidson</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of HPB and Liver Transplant Surgery</POSITION>
<EMAIL_1>b.davidson@medsch.ucl.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>University Department of Surgery</DEPARTMENT>
<ORGANISATION>Royal Free Hospital and University College School of Medicine</ORGANISATION>
<ADDRESS_1>Pond Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP>NW3 2QG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 207 830 2757</PHONE_1>
<PHONE_2/>
<FAX_1>+44 207 830 2688</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-06-30 19:06:18 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NOTES="&lt;p&gt;Minor update: 11/01/08&lt;/p&gt;&lt;p&gt;New studies found and included or excluded: 12/09/06&lt;/p&gt;&lt;p&gt;Conclusions changed: 27/09/07&lt;/p&gt;" NOTES_MODIFIED="2008-06-30 19:06:18 +0100" NOTES_MODIFIED_BY="Kurinchi S Gurusamy">
<UP_TO_DATE>
<DATE DAY="27" MONTH="3" YEAR="2008"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="27" MONTH="3" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="11" MONTH="12" YEAR="2008"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2008"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2008-08-25 13:05:18 +0100" MODIFIED_BY="dimitrinka nikolova"/>
<HISTORY MODIFIED="2008-08-25 13:05:18 +0100" MODIFIED_BY="dimitrinka nikolova">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-08-25 13:05:18 +0100" MODIFIED_BY="dimitrinka nikolova">
<DATE DAY="14" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2008-08-25 13:04:33 +0100" MODIFIED_BY="dimitrinka nikolova">
<INTERNAL_SOURCES MODIFIED="2008-08-25 13:04:33 +0100" MODIFIED_BY="dimitrinka nikolova">
<SOURCE MODIFIED="2008-08-25 13:04:33 +0100" MODIFIED_BY="dimitrinka nikolova">
<NAME>none</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2008-06-30 07:18:26 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<SOURCE MODIFIED="2008-06-30 07:18:26 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<NAME>none</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-11-12 11:21:06 +0100" MODIFIED_BY="dimitrinka nikolova">
<SUMMARY MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<TITLE MODIFIED="2008-09-22 12:51:41 +0100" MODIFIED_BY="dimitrinka nikolova">Clamp-crush technique seems to be the method of choice in liver parenchymal transection</TITLE>
<SUMMARY_BODY MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Liver resection (removal of a part of the liver) is performed mainly for cancerous and non-cancerous tumours in the liver. About 1000 liver resections are performed each year in the United Kingdom. Blood loss during liver resection is one of the main factors affecting the development of surgical complications. Different parenchymal transection techniques (techniques used to divide the liver) have been suggested to decrease blood loss. In this systematic review of seven randomised clinical trials including 556 patients, various methods of parenchymal transection techniques were compared. The infective complications and transection blood loss were greater in the radio frequency dissecting sealer (RFDS ) than clamp-crush technique. There were no significant differences in the mortality or in the morbidity between the other techniques of parenchymal transection. There was also no difference in the markers of liver parenchymal injury or liver dysfunction between the different methods used. Intensive therapy unit stay and hospital stay were similar. The blood transfusion requirements were lower in the clamp-crush technique than CUSA (cavitron ultrasonic surgical aspirator) and hydrojet. There was no difference in the transfusion requirements of clamp-crush technique and sharp dissection. Clamp-crush technique is quicker than CUSA, hydrojet, and RFDS. The transection speed of sharp dissection and clamp-crush technique was not compared. There was no clinically or statistically significant difference in the operating time between sharp dissection and clamp-crush techniques. Clamp-crush technique is two to six times cheaper than the other methods depending upon the number of surgeries performed each year. Clamp-crush technique is advocated as the method of choice in liver parenchymal transection because it avoids the need for special equipment and the newer methods do not seem to offer any benefit in decreasing the morbidity or transfusion requirement.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-09-29 10:31:40 +0100" MODIFIED_BY="dimitrinka nikolova">
<ABS_BACKGROUND>
<P>Blood loss during elective liver resection is one of the main factors affecting the surgical outcome. Different parenchymal transection techniques have been suggested to decrease blood loss.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess the benefits and risks of the different techniques of parenchymal transection during liver resections.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-09-29 10:29:56 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>We searched <I>The Cochrane Hepato-Biliary Group Controlled Trials Register</I>, the <I>Cochrane Central Register of Controlled Trials (CENTRAL)</I> in <I>The Cochrane Library</I>, <I>MEDLINE, EMBASE</I>, and <I>Science Citation Index Expanded </I>(March 2008).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>We considered for inclusion all randomised clinical trials comparing different methods of parenchymal dissection irrespective of the method of vascular occlusion or any other measures used for lowering blood loss.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-09-29 10:31:40 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Two authors identified the trials and extracted the data on the population characteristics, bias risk, mortality, morbidity, blood loss, transection speed, and hospital stay independently of each other. We calculated the odds ratio (OR), mean difference (MD), or standardised mean difference (SMD) with 95% confidence intervals based on 'interntion-to-treat analysis' or 'available case analysis' using RevMan 5.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-09-29 10:21:43 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>We included seven trials randomising 556 patients. The comparisons include CUSA (cavitron ultrasound surgical aspirator) versus clamp-crush (two trials); radiofrequency dissecting sealer (RFDS) versus clamp-crush (two trials); sharp dissection versus clamp-crush technique (one trial); and hydrojet versus CUSA (one trial). One trial compared CUSA, RFDS, hydrojet, and clamp-crush technique. The infective complications and transection blood loss were greater in the RFDS than clamp-crush. There was no difference in the blood transfusion requirements, intensive therapy unit (ITU) stay, or hospital stay in this comparison. There was no significant differences in the mortality, morbidity, markers of liver parenchymal injury or liver dysfunction, ITU, or hospital stay in the other comparisons. The blood transfusion requirements were lower in the clamp-crush technique than CUSA and hydrojet. There was no difference in the transfusion requirements of clamp-crush technique and sharp dissection. Clamp-crush technique is quicker than CUSA, hydrojet, and RFDS. The transection speed of sharp dissection and clamp-crush technique was not compared. There was no clinically or statistically significant difference in the operating time between sharp dissection and clamp-crush techniques. Clamp-crush technique is two to six times cheaper than the other methods depending upon the number of surgeries performed each year.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2008-09-29 10:27:22 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Clamp-crush technique is advocated as the method of choice in liver parenchymal transection because it avoids special equipment, whereas the newer methods do not seem to offer any benefit in decreasing the morbidity or transfusion requirement.<BR/>
</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-12 11:21:06 +0100" MODIFIED_BY="dimitrinka nikolova">
<BACKGROUND MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Elective liver parenchymal resection is performed, among others, for benign and malignant liver tumours (<LINK REF="REF-Belghiti-1993" TYPE="REFERENCE">Belghiti 1993</LINK>). The other main reason for liver resection is living donor liver resection (<LINK REF="REF-Bombuy-2004" TYPE="REFERENCE">Bombuy 2004</LINK>). The malignant tumours may arise primarily within the liver (hepatocellular carcinoma and cholangiocarcinoma) or may be metastases from malignancies of other organs (<LINK REF="REF-Belghiti-1993" TYPE="REFERENCE">Belghiti 1993</LINK>; <LINK REF="REF-Fong-1996" TYPE="REFERENCE">Fong 1996</LINK>). More than 1000 elective liver resections are performed annually in the United Kingdom alone (<LINK REF="REF-HES-2005" TYPE="REFERENCE">HES 2005</LINK>).</P>
<P>The liver resections could be anatomical resections (resection of Couinaud segments) or can be non-anatomical resections (wedge resections or resections that extend across Couinaud's segmental planes) (<LINK REF="REF-Liu-2004" TYPE="REFERENCE">Liu 2004</LINK>). The anatomical liver resections (as per International Hepato-Pancreato-Biliary Association Brisbane 2000 terminology of liver anatomy and resections) include right hemi-hepatectomy (Couinaud segments 5-8 ±1), left hemi-hepatectomy (segments 2 through 4 ±1), right trisectionectomy (segments 4 through 8 ±1), left trisectionectomy (segments 2 through 5, 8 ±1), right anterior sectionectomy (segments 5, 8), right posterior sectionectomy (segments 6, 7), left medial sectionectomy (segment 4), left lateral sectionectomy (segments 2, 3), segmentectomy (any segment), and bisegmentectomy (any 2 segments in continuity) (<LINK REF="REF-Strasberg-2000" TYPE="REFERENCE">Strasberg 2000</LINK>). Although every liver resection is considered a major surgery, only resection of three or more segments is a considered a major liver resection (<LINK REF="REF-Belghiti-1993" TYPE="REFERENCE">Belghiti 1993</LINK>).</P>
<P>Blood loss during liver resection is one of the factors affecting the peri-operative outcomes of patients (<LINK REF="REF-Shimada-1998" TYPE="REFERENCE">Shimada 1998</LINK>; <LINK REF="REF-Yoshimura-2004" TYPE="REFERENCE">Yoshimura 2004</LINK>; <LINK REF="REF-Ibrahim-2006" TYPE="REFERENCE">Ibrahim 2006</LINK>). Various techniques have been attempted to reduce the blood loss during liver resection. These include lowering the central venous pressure (<LINK REF="REF-Wang-2006" TYPE="REFERENCE">Wang 2006</LINK>), hypoventilation (<LINK REF="REF-Hasegawa-2002" TYPE="REFERENCE">Hasegawa 2002</LINK>), or vascular occlusion (<LINK REF="REF-Belghiti-1996" TYPE="REFERENCE">Belghiti 1996</LINK>; <LINK REF="REF-Belghiti-1999" TYPE="REFERENCE">Belghiti 1999</LINK>). Various techniques of liver parenchymal transection have been suggested to decrease blood loss. These include the finger fracture technique (<LINK REF="REF-Rui-2003" TYPE="REFERENCE">Rui 2003</LINK>), sharp dissection (<LINK REF="REF-Smyrniotis-2002" TYPE="REFERENCE">Smyrniotis 2002</LINK>; <LINK REF="STD-Smyrniotis-2005" TYPE="STUDY">Smyrniotis 2005</LINK>), Kelly's technique (clamp-crush technique) (<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), ultrasonic dissector (cavitron ultrasonic surgical aspirator or CUSA) (<LINK REF="STD-Rau-1996" TYPE="STUDY">Rau 1996</LINK>; <LINK REF="STD-Rau-2001" TYPE="STUDY">Rau 2001</LINK>; <LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>; <LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), hydrojet (<LINK REF="STD-Rau-1996" TYPE="STUDY">Rau 1996</LINK>; <LINK REF="STD-Rau-2001" TYPE="STUDY">Rau 2001</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), or a radiofrequency (RF) dissecting sealer (<LINK REF="REF-Weber-2002" TYPE="REFERENCE">Weber 2002</LINK>; <LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>). Among these, the finger fracture technique, the clamp-crush technique, and sharp dissection do not require any special instruments. The finger fracture technique and the clamp-crush technique are generally considered the standard forms of liver parenchymal transection (<LINK REF="REF-Lin-1987" TYPE="REFERENCE">Lin 1987</LINK>).</P>
<P>Lesurtel et al found that the clamp-crushing technique results in lower operative blood loss and decreased parenchymal transection time than CUSA, hydrojet, and RF dissecting sealer (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>). Arita et al found no significant difference in the blood loss or parenchymal transection time between the clamp-crushing technique and the dissecting sealer (<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>).</P>
<P>Both these studies did not find any difference in plasma enzyme markers of liver damage, ie, aspartate transaminase (AST) (<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>) and alanine transaminase (ALT) (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>) activities. Both these studies did not find any difference in the morbidity between the different techniques (<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>). <LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK> found higher number of air emboli in the right heart after liver parenchymal transection using CUSA than that found after liver parenchymal transection using clamp crush technique.</P>
<P>We were not able to identify any systematic reviews or meta-analyses related to parenchymal transection techniques in liver resection.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-09-22 12:48:27 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>To assess the benefits and harms of the different techniques of parenchymal transection during elective liver resections.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-12 11:21:06 +0100" MODIFIED_BY="dimitrinka nikolova">
<SELECTION_CRITERIA MODIFIED="2008-09-29 10:18:05 +0100" MODIFIED_BY="dimitrinka nikolova">
<CRIT_STUDIES MODIFIED="2008-09-26 12:29:57 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>We considered for the review only randomised clinical trials (irrespective of language, blinding, or publication status).</P>
<P>We excluded quasi-randomised studies, where the method of allocating participants to a treatment are not strictly random (eg, date of birth, hospital record number, alternation), cohort studies, and case-control studies).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Patients who are about to undergo elective liver resection for benign or malignant liver tumour or living donor liver resection. </P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-09-26 14:41:28 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>We included trials comparing one method of parenchymal transection with another method of parenchymal transection irrespective of whether the underlying liver was normal or has chronic liver disease; vascular occlusion was used; the method of management of the raw surface; or whether liver resection was associated with or without bile duct excision (ie, with or without bilio-enteric anastomoses).</P>
<P>Co-interventions (including radioablation) were allowed provided that they are used equally in the intervention groups.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-09-29 10:18:05 +0100" MODIFIED_BY="dimitrinka nikolova">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-09-29 10:17:31 +0100" MODIFIED_BY="dimitrinka nikolova">
<OL>
<LI>Mortality (peri-operative mortality and mortality at maximal follow-up).</LI>
<LI>Peri-operative morbidity (such as re-operations for bleeding, bile leakage, etc).</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-09-29 10:18:05 +0100" MODIFIED_BY="dimitrinka nikolova">
<OL>
<LI>Blood loss (during resection and total operative blood loss) and transfusion requirements (number of units, number of patients requiring blood transfusion).</LI>
<LI>Biochemical markers of liver damage (aspartate aminotransferase (AST), alanine aminotransferase (ALT)), and markers of liver function (bilirubin, prothrombin time) (liver function tests).</LI>
<LI>Parenchymal transection time; speed; total operating time.</LI>
<LI>Hospital stay (intensive therapy unit stay or total hospital stay).</LI>
<LI>Costs as reported by authors.</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-10-27 16:46:09 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>We searched <I>The Cochrane Hepato-Biliary Group Controlled Trials Register (</I>
<LINK REF="REF-Gluud-2008" TYPE="REFERENCE">Gluud 2008</LINK>)<I>, </I>the<I> Cochrane Central Register of Controlled Trials (CENTRAL) </I>in<I> The Cochrane Library</I>,<I> MEDLINE</I>, <I>EMBASE</I>, and <I>Science Citation Index Expanded</I> (<LINK REF="REF-Royle-2003" TYPE="REFERENCE">Royle 2003</LINK>). We have given the search strategies in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> with the time span for the searches.</P>
<P>We also searched the references of the identified trials to identify further relevant trials.</P>
<P>We also contacted manufacturers of liver parenchymal transection devices (Radionics (ValleyLab): manufacturers of CUSA; Salient Surgical Technologies (TissueLink) and Angiodynamics: manufacturers of RFDS; Mitsubishi MC Machinery Systems and ERBE: manufacturers of hydrojet and inquired of any unpublished trials. Angiodynamics and Erbe sent us replies in November, but there were no new trials. </P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-11-12 11:21:06 +0100" MODIFIED_BY="dimitrinka nikolova">
<SUBSECTION>
<HEADING LEVEL="3">Trial selection and extraction of data</HEADING>
<P>We did not apply any language or publication status restrictions. KGS and VP, independently of each other, identified the trials for inclusion. We have also listed the excluded trials with the reasons for the exclusion.</P>
<P>KGS and VP extracted the following data independently:</P>
<OL>
<LI>Year and language of publication.</LI>
<LI>Country of study.</LI>
<LI>Year of study.</LI>
<LI>Inclusion and exclusion criteria.</LI>
<LI>Sample size.</LI>
<LI>Population characteristics such as age and gender ratio.</LI>
<LI>Major or minor liver resections.</LI>
<LI>Normal or cirrhotic livers.</LI>
<LI>Method of vascular occlusion.</LI>
<LI>Management of the raw surface.</LI>
<LI>Outcomes mentioned above.</LI>
<LI>Methodological quality (described below).</LI>
</OL>
<P>KGS and VP also assessed the methodological quality of the trials independently, without masking of the study names. Any unclear or missing information was sought by contacting the authors of the individual trials. There was no doubt whether the trials shared the same patients - completely or partially.</P>
<P>The authors resolved any differences in opinion through discussion.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of methodological quality</HEADING>
<P>The authors followed the instructions given in <I>The</I> <I>Cochrane Handbook for Systematic Reviews of Intervention</I> (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>) and <I>The Cochrane Hepato-Biliary Group Module</I> (<LINK REF="REF-Gluud-2008" TYPE="REFERENCE">Gluud 2008</LINK>).</P>
<P>Due to the risk of overestimation of intervention effects in randomised trials with inadequate methodological quality (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>; <LINK REF="REF-Moher-1998" TYPE="REFERENCE">Moher 1998</LINK>; <LINK REF="REF-Kjaergard-2001" TYPE="REFERENCE">Kjaergard 2001</LINK>; <LINK REF="REF-Wood-2008" TYPE="REFERENCE">Wood 2008</LINK>), we looked at the influence of methodological quality of the trials on the trial results by evaluating the reported randomisation and follow-up procedures in each trial. If information was not available in the published trial, we contacted the authors in order to assess the trials correctly. We assessed the following components:</P>
<SUBSECTION>
<HEADING LEVEL="4">Generation of the allocation sequence</HEADING>
<UL>
<LI>Adequate, if the allocation sequence was generated by a computer or random number table. Drawing of lots, tossing of a coin, shuffling of cards, or throwing dice was considered as adequate if a person who was not otherwise involved in the recruitment of participants performed the procedure.</LI>
<LI>Unclear, if the trial was described as randomised, but the method used for the allocation sequence generation was not described.</LI>
<LI>Inadequate, if a system involving dates, names, or admittance numbers was used for the allocation of patients. These studies are known as quasi-randomised and were excluded from the review.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<UL>
<LI>Adequate, if the allocation of patients involved a central independent unit, on-site locked computer, or sealed envelopes. In addition, if there was no blinding in the trials, the allocation concealment was considered adequate only if blocked randomisation was not used or if the blocks were of variable size or if the blocks were distributed across multiple centres such that it is not possible to predict the block size in a single centre.</LI>
<LI>Unclear, if the trial was described as randomised, but the method used to conceal the allocation was not described. In addition, if there was no blinding in the trials, the allocation concealment was considered unclear if it was not clear whether blocked randomisation was used or if the method of blocked randomisation was not described.</LI>
<LI>Inadequate, if the allocation sequence was known to the investigators who assigned participants or if the study was quasi-randomised (such studies were excluded). In addition, if there was no blinding in the trials, the allocation concealment was considered inadequate if it was possible to predict future assignments of participants based on previous assignments such as when fixed size blocks were used in a single centre trial. However, such trials were considered for inclusion in the review</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Blinding</HEADING>
<P>It is not possible to blind the health-care provider (surgeon) to the groups. However, it is possible to blind the patients and the outcome assessors. So, blinding was considered adequate if patients and outcome assessors were blinded.</P>
<UL>
<LI>Adequate, if the patients and outcome assessors were blinded, and the method of blinding was described.</LI>
<LI>Unclear, if the patients and outcome assessors were blinded, and the method of blinding was not described.</LI>
<LI>Inadequate, if the patients and outcome assessors were not blinded.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Incomplete data outcomes</HEADING>
<UL>
<LI>Adequate, if there were no post-randomisation drop-outs or withdrawals or if the post-randomisation drop-outs were balanced in both groups or reasons for missing data were unlikely to be related to true outcome (for example, patients did not undergo surgery after randomisation).</LI>
<LI>Unclear, if it is not clear whether there were any drop-outs or withdrawals or if the reasons for these drop-outs were not clear.</LI>
<LI>Inadequate, if the reasons for missing data are likely to be related to true outcomes, 'as-treated' analysis was performed, potentially inappropriate application of simple imputation, potential for patients with missing outcomes to induce clinically relevant bias in effect estimate or effect size.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Selective outcome reporting</HEADING>
<UL>
<LI>Adequate, if all the important outcomes were reported or if the trial's protocol was available and all of the trial's pre-specified (primary and secondary) outcomes that are of interest in the review have been reported.</LI>
<LI>Unclear, if there is insufficient information to assess whether the risk of selective outcome reporting is present.</LI>
<LI>Inadequate, if not all the pre-specified outcomes were reported or if the primary outcomes were changed or if some of the important outcomes were incompletely reported.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other biases</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Baseline imbalance</HEADING>
<UL>
<LI>Adequate, if there was no baseline imbalance in important characteristics.</LI>
<LI>Unclear, if the baseline characteristics were not reported.</LI>
<LI>Inadequate, if there was a baseline imbalance due to chance or due to imbalanced exclusion after randomisation.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Early stopping</HEADING>
<UL>
<LI>Adequate (sample size calculation was reported and the trial was not stopped or the trial was stopped early by a formal stopping rule at a point where the likelihood of observing an extreme intervention effect due to chance was low).</LI>
<LI>Unclear (sample size calculations were not reported and it is not clear whether the trial was stopped early or not).</LI>
<LI>Inadequate (the trial was stopped early due to an informal stopping rule or the trial was stopped early by a formal stopping rule at a point where the likelihood of observing an extreme intervention effect due to chance was high).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Academic bias</HEADING>
<UL>
<LI>Adequate (the author of the trial has not conducted previous trials addressing the same interventions).</LI>
<LI>Unclear (It is not clear if the author has conducted previous trials addressing the same interventions).</LI>
<LI>Inadequate (the author of the trial has conducted previous trials addressing the same interventions).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Sponsor bias</HEADING>
<UL>
<LI>Adequate, if the trial was unfunded or was not funded by an equipment manufacturer.</LI>
<LI>Unclear, if the source of funding was not clear.</LI>
<LI>Inadequate, if the trial was funded by an equipment manufacturer.</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Statistical methods</HEADING>
<P>We performed the meta-analyses according to the recommendations of The Cochrane Collaboration (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). We used the software package RevMan 5 (<LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>) provided by the Cochrane Collaboration. For dichotomous outcomes, we calculated the odds ratio with 95% confidence interval. For continuous outcomes, we calculated mean difference (MD) or standardised mean difference (SMD) with 95% confidence interval (CI). We used a random-effects model (<LINK REF="REF-DerSimonian-1986" TYPE="REFERENCE">DerSimonian 1986</LINK>) and a fixed-effect model (<LINK REF="REF-DeMets-1987" TYPE="REFERENCE">DeMets 1987</LINK>). In case of discrepancy between the two models, we reported both results; otherwise we have reported only the results from the fixed-effect model. Heterogeneity was explored by chi-squared test with significance set at P value 0.10, and the quantity of heterogeneity was measured by I<SUP>2</SUP> (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>). An I<SUP>2</SUP> &gt; 30% was considered statistically significant heterogeneity. We performed the analysis on an 'intention-to-treat' basis <U>(</U>
<LINK REF="REF-Newell-1992" TYPE="REFERENCE">Newell 1992</LINK>) whenever possible. Otherwise, we adopted the 'available case analysis'. In case we found 'zero-event' trials for statistically significant outcomes, we planned to perform a sensitivity analysis with and without empirical continuity correction factors as suggested by Sweeting et al (<LINK REF="REF-Sweeting-2004" TYPE="REFERENCE">Sweeting 2004</LINK>). However, we did not find any such outcomes.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis</HEADING>
<P>We planned to perform the subgroup analyses for:<BR/>- Normal livers and chronic liver disease.<BR/>- Liver resections versus living donor retrievals.<BR/>- Minor and major liver resections.<BR/>- Different techniques of vascular occlusion.<BR/>- Different techniques of management of raw surface.<BR/>- Trials with low and high risk of bias.</P>
<P>However, we did not perform any of the subgroup analysis because of the few trials included under each outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analysis</HEADING>
<P>One of the trials used vascular occlusion in the clamp-crush technique only (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>). We performed a sensitivity analysis excluding this trial from all comparisons involving clamp-crush technique. This was a post-hoc decision following comments from peer reviewers and editors.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Bias exploration</HEADING>
<P>We planned to use a funnel plot to explore bias (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>; <LINK REF="REF-Macaskill-2001" TYPE="REFERENCE">Macaskill 2001</LINK>). Asymmetry in funnel plot of trial size against treatment effect was to be used to assess bias. We also intended to perform linear regression approach described by Egger et al to determine the funnel plot asymmetry (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>). However, we did not perform any of the above because of the few trials included under each outcome.</P>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<STUDY_DESCRIPTION MODIFIED="2008-09-27 17:05:01 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>We identified a total of 887 references through the electronic searches of The Cochrane Hepato-Biliary Group Controlled Trials Register and the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library (n = 107), MEDLINE (n = 393), EMBASE (n = 242), and Science Citation Index Expanded (n = 145). We excluded 288 duplicates and 591 clearly irrelevant references through reading abstracts. Eight references were retrieved for further assessment. No references were identified through scanning reference lists of the identified randomised trials. We excluded one reference (<LINK REF="STD-Rau-1996" TYPE="STUDY">Rau 1996</LINK>) because of the reason listed under the table 'Characteristics of excluded studies'. The remaining seven references were references of seven completed randomised trials, which fulfilled the inclusion criteria (<LINK REF="STD-Rau-2001" TYPE="STUDY">Rau 2001</LINK>; <LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>; <LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>; <LINK REF="STD-Smyrniotis-2005" TYPE="STUDY">Smyrniotis 2005</LINK>; <LINK REF="STD-Lupo-2007" TYPE="STUDY">Lupo 2007</LINK>). Details of the trials are shown in the table 'Characteristics of included studies'.</P>
<SUBSECTION>
<HEADING LEVEL="3">Participants</HEADING>
<P>A total of 556 participants undergoing elective liver resection were randomised in the seven trials. The number of participants in each trial ranged from 50 to 132. We were not able to extract relevant data on the sex ratio of the participants from one trial (<LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>). The proportion of females was 32.4% in the remaining trials. The mean or median age in the trials varied between 52.7 years and 68 years. Information on the number of major resections was not available in one trial (<LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>). The proportion of major liver resections was 45.3% in the remaining trials. None of the trials included living donor liver retrievals.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparisons</HEADING>
<P>The different comparisons are stated in the 'Characteristics of included studies'. The comparisons include CUSA versus clamp-crush technique (two trials - <LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>; <LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>); radio frequency dissecting sealer (RFDS) versus clamp-crush (two trials - <LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Lupo-2007" TYPE="STUDY">Lupo 2007</LINK>); sharp dissection versus clamp-crush technique (one trial - <LINK REF="STD-Smyrniotis-2005" TYPE="STUDY">Smyrniotis 2005</LINK>); and hydrojet versus CUSA (one trial - <LINK REF="STD-Rau-2001" TYPE="STUDY">Rau 2001</LINK>). One trial (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>) compared CUSA, RFDS, hydrojet, and clamp-crush technique.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcome measures</HEADING>
<P>The outcome measures reported by the different trials were peri-operative mortality (<LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>; <LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>; <LINK REF="STD-Smyrniotis-2005" TYPE="STUDY">Smyrniotis 2005</LINK>; <LINK REF="STD-Lupo-2007" TYPE="STUDY">Lupo 2007</LINK>), surgery related complications (<LINK REF="STD-Rau-1996" TYPE="STUDY">Rau 1996</LINK>; <LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>; <LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>; <LINK REF="STD-Smyrniotis-2005" TYPE="STUDY">Smyrniotis 2005</LINK>; <LINK REF="STD-Lupo-2007" TYPE="STUDY">Lupo 2007</LINK>), air embolism (<LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>), blood loss (<LINK REF="STD-Rau-2001" TYPE="STUDY">Rau 2001</LINK>; <LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>; <LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>; <LINK REF="STD-Smyrniotis-2005" TYPE="STUDY">Smyrniotis 2005</LINK>); number of patients transfused (<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>; <LINK REF="STD-Smyrniotis-2005" TYPE="STUDY">Smyrniotis 2005</LINK>; <LINK REF="STD-Lupo-2007" TYPE="STUDY">Lupo 2007</LINK>); amount of blood transfused (<LINK REF="STD-Rau-1996" TYPE="STUDY">Rau 1996</LINK>; <LINK REF="STD-Rau-2001" TYPE="STUDY">Rau 2001</LINK>; <LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>), operating time (<LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>; <LINK REF="STD-Smyrniotis-2005" TYPE="STUDY">Smyrniotis 2005</LINK>), transection time (<LINK REF="STD-Rau-2001" TYPE="STUDY">Rau 2001</LINK>; <LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>; <LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>), transection speed (<LINK REF="STD-Rau-1996" TYPE="STUDY">Rau 1996</LINK>; <LINK REF="STD-Rau-2001" TYPE="STUDY">Rau 2001</LINK>; <LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>; <LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), markers of liver parenchymal injury (<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), markers of liver dysfunction (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), intensive therapy unit (ITU) stay (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>; <LINK REF="STD-Smyrniotis-2005" TYPE="STUDY">Smyrniotis 2005</LINK>), and hospital stay (<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>; <LINK REF="STD-Smyrniotis-2005" TYPE="STUDY">Smyrniotis 2005</LINK>; <LINK REF="STD-Lupo-2007" TYPE="STUDY">Lupo 2007</LINK>).</P>
<P>The other outcome measures reported by the trials were air embolisms to the heart (<LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>), costs (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), and tumour exposure at margin (<LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>).</P>
</SUBSECTION>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-09-26 10:37:56 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The risk of bias is summarised in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>. Out of the seven trials, five (71.4%) had adequate generation of the allocation sequence (<LINK REF="STD-Rau-2001" TYPE="STUDY">Rau 2001</LINK>; <LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>; <LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>; <LINK REF="STD-Lupo-2007" TYPE="STUDY">Lupo 2007</LINK>); three trials (42.9%) had adequate allocation concealment (<LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>
<U>; </U>
<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>
<U>; </U>
<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>
<U>)</U>. None of the trials reported on blinding of patients or outcome assessors. All the trials had addressed incomplete outcome data adequately. Five trials (71.4%) reported on the important outcomes and were free of selective outcome reporting (<LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>
<U>; </U>
<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>
<U>; </U>
<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>
<U>; </U>
<LINK REF="STD-Smyrniotis-2005" TYPE="STUDY">Smyrniotis 2005</LINK>
<U>; </U>
<LINK REF="STD-Lupo-2007" TYPE="STUDY">Lupo 2007</LINK>). Three of these five trials (42.9%) were free from all the other biases (<LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>
<U>; </U>
<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>
<U>; </U>
<LINK REF="STD-Lupo-2007" TYPE="STUDY">Lupo 2007</LINK>). All the trials were considered to be of high risk of bias because of the lack of blinding in all the trials.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>This review is based on seven trials including 556 patients. None of the trials reported long term mortality. So, all the mortality reported was peri-operative mortality.</P>
<SUBSECTION>
<HEADING LEVEL="3">CUSA versus clamp-crush technique</HEADING>
<P>In the three trials that provided comparison between CUSA and clamp-crush (<LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>; <LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), 232 patients were randomised to either CUSA (116 patients) or clamp-crush (116 patients) techniques.</P>
<P>Since one trial (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>) compared CUSA without vascular occlusion and clamp-crush technique with vascular occlusion, we considered this trial to be different from the other two (<LINK REF="STD-Takayama-2001" TYPE="STUDY">Takayama 2001</LINK>; <LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>) and analysed it separately.</P>
<SUBSECTION>
<HEADING LEVEL="4">Trials where vascular occlusion was equal between groups</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Mortality and morbidity</HEADING>
<P>There was no statistically significant difference between the two groups in the mortality or in morbidity. The number of patients with air embolism detected in the heart by echocardiography was statistically significantly higher in the CUSA group (odds ratio OR 24.77, 95% CI 1.34 to 457.61). However, none of the patients had clinically significant air embolism.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Blood loss and transfusion requirements</HEADING>
<P>There was no difference in the operative blood loss, in the median transection blood loss (330 versus 325 ml/sq cm), or in the amount of blood transfused.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Transection speed</HEADING>
<P>There was no statistically significant difference in the operating time or the transection time.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Trial of CUSA without vascular occlusion and clamp-crush technique with vascular occlusion</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Mortality and morbidity</HEADING>
<P>There was no statistically significant difference between the two groups in the mortality and morbidity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Blood loss and transfusion requirements</HEADING>
<P>There was a statistically significant difference in the amount of blood loss per sq cm (mean difference MD 2.50, 95% CI 1.01 to 3.99). A statistically significant higher number of people undergoing liver transection by CUSA technique required blood transfusion than those undergoing liver resection by clamp-crush technique (OR 11.29, 95% CI 1.29 to 98.89).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Liver function tests</HEADING>
<P>There was no statistically significant difference in the AST, or ALT, or bilirubin level or prothrombin activity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Transection speed</HEADING>
<P>The transection speed was statistically significantly quicker (MD 1.60 sq cm/min, 95% CI 0.89 to 2.31) in the clamp-crush method than the CUSA.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Stay</HEADING>
<P>There was no statistically significant difference in the median intensive therapy unit (ITU) or hospital stay between the two groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Costs</HEADING>
<P>Costs were calculated in one trial (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>) based on the transection speed, blood loss, and cost of the maintenance of the instrument. The CUSA was 3 to 6 times costlier than clamp-crush technique depending upon the number of cases performed per year.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">RFDS versus clamp-crush technique</HEADING>
<P>In the three trials that provided a comparison between RFDS and clamp-crush (<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>; <LINK REF="STD-Lupo-2007" TYPE="STUDY">Lupo 2007</LINK>), 180 patients were randomised to either the RFDS (89 patients) or clamp-crush (91 patients) techniques. The results of the meta-analysis and the data from the trials that could not be included in a meta-analysis are tabulated in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="5">Mortality and morbidity</HEADING>
<P>There was no mortality in either group. The infected intra-abdominal collections were significantly higher in the RFDS group than clamp-crush group (OR 11.02, 95% CI 1.38 to 88.28). Wound infection approached statistical significance favouring the clamp-crush technique (OR 7.58, 95% CI 0.8 to 68.46).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Blood loss and transfusion requirements</HEADING>
<P>There was a higher transection blood loss in the RFDS group than clamp-crush group (MD 1.90, 95% CI 0.92 to 2.88). There was no difference in the number of people requiring blood transfusion between the two groups (OR 1.19, 95% CI 0.50 to 2.82). The amount of blood transfused could not be estimated as none in the clamp-crush group underwent blood transfusion in the only trial (<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>) that reported on this outcome. By imputing a value of 0.01 and 0.01 for mean and standard deviation instead of 0 and 0, we could calculate a mean difference. This was statistically significantly lower in the clamp-crush method (number of units: MD 1.49 units; 95% CI 1.27 to 1.71; amount of blood transfused: MD 359.99 ml; 95% CI 307.31 to 412.67). </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Liver function tests</HEADING>
<P>There was no statistically significant difference in the AST, or ALT, or bilirubin level, or prothrombin activity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Transection speed</HEADING>
<P>The transection speed was statistically significantly quicker (MD 1.40 sq cm/min, 95% CI 0.57 to 2.23) in the clamp-crush method than the RFDS in the only trial, which reported on this outcome (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>). There was no difference in the median operating time between the two groups in the only trial, which reported on the operating time (<LINK REF="STD-Lupo-2007" TYPE="STUDY">Lupo 2007</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Stay</HEADING>
<P>There was no statistically significant difference in the median intensive therapy unit (ITU) or hospital stay between the two groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Costs</HEADING>
<P>Costs were calculated in one trial (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>) based on the transection speed, blood loss, and cost of the maintenance of the instrument. The RFDS was approximately 3 times costlier than clamp-crush technique.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Sentivity analysis</HEADING>
<P>On exclusion of the trial, which used vascular occlusion in the clamp-crush group alone (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), infected intraabdominal collections favouring clamp-crush technique and the amount of blood transfused (after imputing the mean and standard deviation as mentioned previously) were the only statistically significant differences between the groups. This was because transection speed and costs were reported only in the trial, which was excluded in the sensitivity analysis (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Hydrojet versus clamp-crush technique</HEADING>
<P>In the only trial that provided comparison between hydrojet and clamp-crush (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), 50 patients were randomised to either hydrojet (25 patients) or clamp-crush (25 patients) techniques. In this trial, vascular occlusion was used only in the clamp-crush group.</P>
<SUBSECTION>
<HEADING LEVEL="5">Mortality and morbidity</HEADING>
<P>There was no statistically significant difference between the two groups in the mortality (OR 5.43, 95% CI 0.25 to 118.96) or in morbidity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Blood loss and transfusion requirements</HEADING>
<P>There was greater blood loss (MD 2.00 ml/cm<SUP>2</SUP>, 95% CI 0.86 to 3.14) and higher number of people requiring blood transfusion in the hydrojet group than the clamp-crush group (OR 11.29, 95% 1.29 to 98.89).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Liver function tests</HEADING>
<P>There was no statistically significant difference in the AST or ALT or bilirubin level or prothrombin activity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Transection speed</HEADING>
<P>The transection speed was statistically significantly quicker (MD 1.50 sq cm/min, 95% CI 0.67 to 2.33) in the clamp-crush method than the hydrojet.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Stay</HEADING>
<P>There was no statistically significant difference in the median intensive therapy unit (ITU) (1 day in both groups) or hospital stay (9 days in both groups) between the two groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Costs</HEADING>
<P>Costs were calculated based on the transection speed, blood loss, and cost of the maintenance of the instrument. The hydrojet was approximately 2 to 4 times costlier than clamp-crush technique depending upon the number of cases operated per year.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sharp dissection versus clamp-crush technique</HEADING>
<P>In the only trial that provided comparison between sharp dissection (SD) and clamp-crush (CC) techniques (<LINK REF="STD-Smyrniotis-2005" TYPE="STUDY">Smyrniotis 2005</LINK>), 82 patients were randomised to either sharp dissection (41 patients) or clamp-crush (41 patients) techniques.</P>
<SUBSECTION>
<HEADING LEVEL="5">Mortality and morbidity</HEADING>
<P>There was no mortality in either group. There was no statistically significant difference between the two groups in operative morbidity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Blood loss and transfusion requirements</HEADING>
<P>There was no statistically significant difference in the median operative blood loss (500 ml SD versus 460 ml CC) or the number of people requiring blood transfusion (OR 0.80, 95% CI 0.32 to 2.01).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Transection speed</HEADING>
<P>There was no statistically significant difference in the median operating time (205 min SD versus 211 min CC).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Stay</HEADING>
<P>There was no statistically significant difference in the median intensive therapy unit (ITU) (1 day in both groups) or hospital stay (10 days SD versus 11 days CC) between the two groups.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Hydrojet versus CUSA</HEADING>
<P>In the two trials that provided comparison between hydrojet and CUSA (<LINK REF="STD-Rau-2001" TYPE="STUDY">Rau 2001</LINK>; <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), 111 patients were randomised to either hydrojet (56 patients) or CUSA (55 patients) techniques. The results of the meta-analysis and the data from the trials that could not be included for the meta-analysis are tabulated in <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="5">Mortality and morbidity</HEADING>
<P>There was no statistically significant difference between the two groups in the mortality (OR 1.00, 95% CI 0.13 to 7.72) or in morbidity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Blood loss and transfusion requirements</HEADING>
<P>There was no statistically significant difference in the transection blood loss, operative blood loss, the number of people requiring transfusion or the mean transfusion requirements.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Liver function tests</HEADING>
<P>There was no statistically significant difference in the AST, or ALT, or bilirubin level or prothrombin activity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Transection speed</HEADING>
<P>There was no statistically significant difference in the transection time or transection speed between the two groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Stay</HEADING>
<P>There was no statistically significant difference in the median intensive therapy unit (ITU) or hospital stay between the two groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Costs</HEADING>
<P>Costs were calculated in one trial based on the transection speed, blood loss, and cost of the maintenance of the instrument. The hydrojet was approximately a third cheaper than CUSA (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">RFDS versus CUSA</HEADING>
<P>In the only trial that provided comparison between RFDS and CUSA (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), 50 patients were randomised to either RFDS (25 patients) or CUSA (25 patients) techniques.</P>
<SUBSECTION>
<HEADING LEVEL="5">Mortality and morbidity</HEADING>
<P>There was no statistically significant difference between the two groups in the mortality (OR 5.43, 95% CI 0.25 to 118.96) or in morbidity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Blood loss and transfusion requirements</HEADING>
<P>There was no statistically significant transection blood loss or the number of people requiring blood transfusion between the two groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Liver function tests</HEADING>
<P>There was no statistically significant difference in the AST, or ALT, or bilirubin level, or prothrombin activity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Transection speed</HEADING>
<P>There was no statistically significant difference in the transection speed between the two groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Stay</HEADING>
<P>There was no statistically significant difference in the median intensive therapy unit (ITU) (1 day in both groups) or hospital stay (9 days in both groups) between the two groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Costs</HEADING>
<P>Costs were calculated based on the transection speed, blood loss, and cost of the maintenance of the instrument. Depending upon the number of cases operated, RFDS costs were approximately 50% to 100% of that of CUSA.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">RFDS versus hydrojet</HEADING>
<P>In the only trial that provided comparison between RFDS and hydrojet (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), 50 patients were randomised to either RFDS (25 patients) or hydrojet (25 patients) techniques.</P>
<SUBSECTION>
<HEADING LEVEL="5">Mortality and morbidity</HEADING>
<P>There was no statistically significant difference between the two groups in the mortality (OR 0.18, 95% CI 0.01 to 4.04) or in morbidity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Blood loss and transfusion requirements</HEADING>
<P>There was no statistically significant transection blood loss or the number of people requiring blood transfusion between the two groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Liver function tests</HEADING>
<P>There was no statistically significant difference in the AST, or ALT, or bilirubin level or prothrombin activity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Transection speed</HEADING>
<P>There was no statistically significant difference in the transection speed between the two groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Stay</HEADING>
<P>There was no statistically significant difference in the median intensive therapy unit (ITU) (1 day in both groups) or hospital stay (9 days in both groups) between the two groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Costs</HEADING>
<P>Costs were calculated based on the transection speed, blood loss, and cost of the maintenance of the instrument. RFDS costs about 25% more than the hydrojet.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Funnel plots</HEADING>
<P>Exploration of bias was not done because of the few trials included under each outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis</HEADING>
<P>No subgroup analysis was performed because of the few trials included under each outcome.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-09-26 12:05:02 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>In this systematic review, there were no significant differences in the mortality or in the morbidity (including bile leak) of liver resection irrespective of the method used for parenchymal transection. However, the trials were not adequately powered to identify significant differences in the mortality or morbidity. Markers of liver parenchymal injury or liver dysfunction were also similar and there was no difference in the ITU or hospital stay between the different groups.</P>
<P>In the trial by Koo et al (<LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>), there was a significantly higher number of air embolisms detected in the heart in the CUSA group than the clamp-crush group. All the embolisms that filled half or more of the diameter of the right heart (including some which filled the entire right heart) were in the CUSA group (<LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>). However, none of the patients in either group developed clinical symptoms. The importance of this finding in the absence of clinical symptoms is not clear. But it is likely to reflect the risk of a massive air embolism with CUSA.</P>
<P>Clamp-crush technique appears to have the lowest blood loss and lowest transfusion requirements compared to the different techniques. The trial (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>), which compared clamp-crush technique with three other techniques (CUSA, RFDS, and hydrojet), continuous portal trial clamping was used in the clamp-crush technique, while no inflow occlusion was used for the other techniques (CUSA, RFDS, hydrojet). Another trial (<LINK REF="STD-Koo-2005" TYPE="STUDY">Koo 2005</LINK>) comparing clamp-crush technique with CUSA did not employ vascular occlusion. This trial did not find any difference in the blood transfusion requirements between the two groups. The third trial comparing the clamp-crush technique with CUSA employed intermittent vascular occlusion in both groups. This trial did not report on blood transfusion requirements but reported that the median transection blood loss was similar in the two groups. Thus, it is likely that vascular occlusion played an important role in decreasing the blood transfusion requirements in the clamp-crush technique in the trial where vascular occlusion was used in the clamp-crush technique only. However, the transection speed of clamp-crush technique is higher than the other techniques enabling safe vascular occlusion.Techniques should be assessed as a 'package', ie, a parenchymal transection technique in combination with a particular method of vascular occlusion to find out the best combination.</P>
<P>The transection speed is given more importance than the operating time as this takes the transection area into account. Clamp-crush technique is quicker than CUSA, hydrojet, and RFDS. The transection speed of sharp dissection and clamp-crush technique was not compared. There was no clinically or statistically significant difference in the operating time between sharp dissection and clamp-crush techniques. Since the primary aim of vascular occlusion is reducing the blood loss, the use of vascular occlusion is clearly a confounding factor. Whether vascular occlusion is necessary and whether there is an 'ideal' method of vascular occlusion is a matter of controversy (<LINK REF="REF-Gurusamy-2007" TYPE="REFERENCE">Gurusamy 2007</LINK>). In this review, we found that intermittent vascular occlusion is safe and decreases blood loss and blood transfusion requirements, but it did not affect the morbidity. Thus, the ideal vascular occlusion method has not been established. The other confounding factors like low central venous pressure, hypoventilation, and use of intravenous drugs like tranexamic acid were not stated in most trials.</P>
<P>The clamp-crush technique and sharp dissection technique do not involve any additional instruments. All the other techniques involve additional equipments. There is no increased mortality or morbidity associated with clamp-crush technique. While the trials were not powered to measure the mortality and morbidity, the sample sizes were enough to detect differences in enzyme markers of liver injury. The clamp-crush technique was not associated with a higher raise of these enzymes than other techniques. None of the trials demonstrated a reduction in transfusion requirements by using special instruments. So, there is no evidence of superiority of any technique over clamp-crush technique. Clamp-crush technique is also quicker than most other interventions (as represented by the transection speed). A cost comparison between clamp-crush technique and other techniques revealed that the clamp-crush technique is two to six times cheaper than the other methods depending upon the number of surgeries performed each year (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>).</P>
<P>The main drawback of this review is the small number of trials in each comparison making it impossible to perform subgroup analyses. The number of patients included for different comparisons ranged from 50 (hydrojet versus clamp-crush; RFDS versus CUSA; RFDS versus hydrojet) to 282 (CUSA versus clamp-crush). This sample size is not sufficiently powered to detect clinically significant differences in the primary outcomes. All the trials were of high risk of bias mainly because of the lack of blinding. While patient blinding can be easily achieved, even this was not reported in the trials, and it is not safe to assume that the patients were blinded to the groups. The outcome assessor blinding is more difficult to achieve. The bias due to lack of blinding can be minimised by using objective outcomes whenever feasible and by involving a second team of surgeons (<LINK REF="REF-Wood-2008" TYPE="REFERENCE">Wood 2008</LINK>). The trials were also not adequately powered to measure differences in the mortality and morbidity in liver resection. So, adequately powered low bias-risk trials are necessary to compare the different techniques of liver resection.</P>
<P>Until low bias-risk randomised clinical trials employing factorial designs to identify the effect of confounding factors such as the method of vascular occlusion, low CVP, and hypoventilation are performed, clamp-crush technique is advocated as the method of choice in liver parenchymal transection because of the low costs and avoidance of special equipment whilst minimising morbidity.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<IMPLICATIONS_PRACTICE MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Clamp-crush technique is advocated as the method of choice in liver parenchymal transection because it avoids the need for special equipment whereas the newer methods do not seem to offer any benefit in decreasing the morbidity or transfusion requirement.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-09-22 13:06:14 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Further randomised clinical trials are needed to compare the different liver parenchymal transection techniques. They have to be with a sufficient sample size, low risk of bias, and employ patient blinding and outcome assessment by blinded assessors. These trials should be reported according to the CONSORT guidelines (http://www.consort-statement.org).</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-09-29 10:16:03 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>TC Mahendran, Chennai, my first surgical teacher.<BR/>Martyn Parker, Peterborough District Hospital, Peterborough who inspired me to write Cochrane Reviews.<BR/>The Cochrane Hepato-Biliary Group for their support.<BR/>
<BR/>Peer Reviewers: P Ghaneh, UK; S Gaujoux, France; D Piccolboni, Italy.<BR/>Contact Editor: N Alexakis, Greece.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>KG identified trials for inclusion, extract data, analyse data, and wrote the draft review. VP is the second author who independently identified trials for inclusion and extracted data. DS and BRD critically commented on the review. All authors approved of the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2008-09-26 11:57:05 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The outcomes have now been classified into primary and secondary outcomes. The method of assessment of bias-risk has been updated in line with the methodology stated in the Cochrane Handbook (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). A sensitivity analysis excluding a trial, which used vascular occlusion in one group was performed following comments from peer reviewers and editors.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova">
<STUDIES MODIFIED="2008-06-30 14:01:53 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<INCLUDED_STUDIES MODIFIED="2008-06-30 14:01:53 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<STUDY DATA_SOURCE="PUB" ID="STD-Arita-2005" NAME="Arita 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arita J, Hasegawa K, Kokudo N, Sano K, Sugawara Y, Makuuchi M</AU>
<TI>Randomized clinical trial of the effect of a saline-linked radiofrequency coagulator on blood loss during hepatic resection</TI>
<SO>The British Journal of Surgery</SO>
<YR>2005</YR>
<VL>92</VL>
<NO>8</NO>
<PG>954-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Koo-2005" NAME="Koo 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Koo BN, Kil HK, Choi JS, Kim JY, Chun DH, Hong YW</AU>
<TI>Hepatic resection by the Cavitron Ultrasonic Surgical Aspirator increases the incidence and severity of venous air embolism</TI>
<SO>Anesthesia Analgesia</SO>
<YR>2005</YR>
<VL>101</VL>
<NO>4</NO>
<PG>966-70, table of contents</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Lesurtel-2005" MODIFIED="2008-06-30 14:01:53 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NAME="Lesurtel 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lesurtel M, Selzner M, Petrowsky H, McCormack L, Clavien PA</AU>
<TI>How should transection of the liver be performed? a prospective randomized study in 100 consecutive patients: comparing four different transection strategies</TI>
<SO>Annals of Surgery</SO>
<YR>2005</YR>
<VL>242</VL>
<NO>6</NO>
<PG>814-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Lupo-2007" MODIFIED="2008-06-30 07:29:03 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NAME="Lupo 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-06-30 07:29:03 +0100" MODIFIED_BY="Kurinchi S Gurusamy" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lupo L, Gallerani A, Panzera P, Tandoi F, Di Palma G, Memeo V</AU>
<TI>Randomized clinical trial of radiofrequency-assisted versus clamp-crushing liver resection</TI>
<SO>The British Journal of Surgery</SO>
<YR>2007</YR>
<VL>94</VL>
<NO>3</NO>
<PG>287-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Rau-2001" NAME="Rau 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rau HG, Wichmann MW, Schinkel S, Buttler E, Pickelmann S, Schauer R, et al</AU>
<TI>[Surgical techniques in hepatic resections: Ultrasonic aspirator versus Jet-Cutter. A prospective randomized clinical trial]</TI>
<SO>Zentralblatt fur Chirurgie</SO>
<YR>2001</YR>
<VL>126</VL>
<NO>8</NO>
<PG>586-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Smyrniotis-2005" NAME="Smyrniotis 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smyrniotis V, Arkadopoulos N, Kostopanagiotou G, Farantos C, Vassiliou J, Contis J, et al</AU>
<TI>Sharp liver transection versus clamp crushing technique in liver resections: a prospective study</TI>
<SO>Surgery</SO>
<YR>2005</YR>
<VL>137</VL>
<NO>3</NO>
<PG>306-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Takayama-2001" NAME="Takayama 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Takayama T, Makuuchi M, Kubota K, Harihara Y, Hui AM, Sano K, et al</AU>
<TI>Randomized comparison of ultrasonic vs clamp transection of the liver</TI>
<SO>Archives of Surgery</SO>
<YR>2001</YR>
<VL>136</VL>
<NO>8</NO>
<PG>922-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Rau-1996" NAME="Rau 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rau HG, Meyer G, Jauch KW, Cohnert TU, Buttler E, Schildberg FW</AU>
<TI>[Liver resection with the water jet: conventional and laparoscopic surgery]</TI>
<SO>Der Chirurg</SO>
<YR>1996</YR>
<VL>67</VL>
<NO>5</NO>
<PG>546-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova">
<ADDITIONAL_REFERENCES MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova">
<REFERENCE ID="REF-Belghiti-1993" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Belghiti 1993" TYPE="JOURNAL_ARTICLE">
<AU>Belghiti J, Kabbej M, Sauvanet A, Vilgrain V, Panis Y, Fekete F</AU>
<TI>Drainage after elective hepatic resection. A randomized trial</TI>
<SO>Annals of Surgery</SO>
<YR>1993</YR>
<VL>218</VL>
<NO>6</NO>
<PG>748-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Belghiti-1996" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Belghiti 1996" TYPE="JOURNAL_ARTICLE">
<AU>Belghiti J, Noun R, Zante E, Ballet T, Sauvanet A</AU>
<TI>Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study</TI>
<SO>Annals of Surgery</SO>
<YR>1996</YR>
<VL>224</VL>
<NO>2</NO>
<PG>155-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Belghiti-1999" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Belghiti 1999" TYPE="JOURNAL_ARTICLE">
<AU>Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F, et al</AU>
<TI>Continuous versus intermittent portal triad clamping for liver resection: a controlled study</TI>
<SO>Annals of Surgery</SO>
<YR>1999</YR>
<VL>229</VL>
<NO>3</NO>
<PG>369-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bombuy-2004" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Bombuy 2004" TYPE="JOURNAL_ARTICLE">
<AU>Bombuy E, Fondevila C, Rodriguez-Laiz G, Ferrer J, Amador A, Valentini M, et al</AU>
<TI>Ischemic preconditioning in adult living donor liver transplantation, a pilot study [EASL abstract]</TI>
<SO>Journal of Hepatology</SO>
<YR>2004</YR>
<VL>40</VL>
<NO>Suppl 1</NO>
<PG>39</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DeMets-1987" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="DeMets 1987" TYPE="JOURNAL_ARTICLE">
<AU>DeMets DL</AU>
<TI>Methods for combining randomized clinical trials: strengths and limitations</TI>
<SO>Statistics in Medicine</SO>
<YR>1987</YR>
<VL>6</VL>
<NO>3</NO>
<PG>341-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DerSimonian-1986" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="DerSimonian 1986" TYPE="JOURNAL_ARTICLE">
<AU>DerSimonian R, Laird N</AU>
<TI>Meta-analysis in clinical trials</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1986</YR>
<VL>7</VL>
<NO>3</NO>
<PG>177-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey SG, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ (Clinical Research Ed.)</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fong-1996" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Fong 1996" TYPE="JOURNAL_ARTICLE">
<AU>Fong Y, Brennan MF, Brown K, Heffernan N, Blumgart LH</AU>
<TI>Drainage is unnecessary after elective liver resection</TI>
<SO>American Journal of Surgery</SO>
<YR>1996</YR>
<VL>171</VL>
<NO>1</NO>
<PG>158-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gluud-2008" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Gluud 2008" NOTES="&lt;p&gt;Gluud C, Als-Nielsen B, D'Amico G, Fingerhut A, Gluud LL, Khan S, Klingenberg SL, Koretz R, Liu JP, Myers R, Nikolova D, Pagliaro L, Simonetti R, Sutton R. Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2006, Issue 3. Art. No.: LIVER&lt;/p&gt;" NOTES_MODIFIED="2008-10-27 16:38:37 +0100" NOTES_MODIFIED_BY="dimitrinka nikolova" TYPE="OTHER">
<AU>Gluud C, Nikolova D, Klingenberg SL, Whitfield K, Alexakis N, Als-Nielsen B, et al</AU>
<TI>Cochrane Hepato-Biliary Group</TI>
<SO>About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2008, Issue 4. Art. No.: LIVER</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gurusamy-2007" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Gurusamy 2007" TYPE="COCHRANE_REVIEW">
<AU>Gurusamy KS, Kumar Y, Sharma D, Davidson BR</AU>
<TI>Methods of vascular occlusion for elective liver resections</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2008-09-09 14:52:37 +0100" MODIFIED_BY="Sarah Louise Klingenberg">
<IDENTIFIER MODIFIED="2008-09-09 14:52:37 +0100" MODIFIED_BY="Sarah Louise Klingenberg" TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD006409.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hasegawa-2002" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Hasegawa 2002" TYPE="JOURNAL_ARTICLE">
<AU>Hasegawa K, Takayama T, Orii R, Sano K, Sugawara Y, Imamura H, et al</AU>
<TI>Effect of hypoventilation on bleeding during hepatic resection: a randomized controlled trial</TI>
<SO>Archives of Surgery</SO>
<YR>2002</YR>
<VL>137</VL>
<NO>3</NO>
<PG>311-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-HES-2005" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="HES 2005" TYPE="OTHER">
<AU>Hospital Episode Statistics</AU>
<TI>Main operations. 3 character: 2004-05</TI>
<SO>http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&amp;categoryID=205</SO>
<YR>(accessed 9 September 2008)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>11</NO>
<PG>1539-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Higgins 2008" TYPE="BOOK">
<AU>Higgins JPT, Green S (editors)</AU>
<SO>Cochrane Handbook for Systematic Reviews of Intervention 5.0.0 [updated February 2008]</SO>
<YR>2008. Available from www.cochrane-handbook.org</YR>
<PB>The Cochrane Colloboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ibrahim-2006" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Ibrahim 2006" TYPE="JOURNAL_ARTICLE">
<AU>Ibrahim S, Chen CL, Lin CC, Yang CH, Wang CC, Wang SH, et al</AU>
<TI>Intraoperative blood loss is a risk factor for complications in donors after living donor hepatectomy</TI>
<SO>Liver Transplantation</SO>
<YR>2006</YR>
<VL>12</VL>
<NO>6</NO>
<PG>950-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kjaergard-2001" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Kjaergard 2001" TYPE="JOURNAL_ARTICLE">
<AU>Kjaergard LL, Villumsen J, Gluud C</AU>
<TI>Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2001</YR>
<VL>135</VL>
<NO>11</NO>
<PG>982-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lin-1987" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Lin 1987" TYPE="JOURNAL_ARTICLE">
<AU>Lin TY, Lee CS, Chen KM, Chen CC</AU>
<TI>Role of surgery in the treatment of primary carcinoma of the liver: a 31-year experience</TI>
<SO>The British Journal of Surgery</SO>
<YR>1987</YR>
<VL>74</VL>
<NO>9</NO>
<PG>839-42</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="2822201"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Liu-2004" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Liu 2004" TYPE="JOURNAL_ARTICLE">
<AU>Liu CL, Fan ST, Lo CM, Wong Y, Ng IO, Lam CM, et al</AU>
<TI>Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases</TI>
<SO>Annals of Surgery</SO>
<YR>2004</YR>
<VL>239</VL>
<NO>2</NO>
<PG>194-201</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Macaskill-2001" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Macaskill 2001" TYPE="JOURNAL_ARTICLE">
<AU>Macaskill P, Walter SD, Irwig L</AU>
<TI>A comparison of methods to detect publication bias in meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2001</YR>
<VL>20</VL>
<NO>4</NO>
<PG>641-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-1998" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Moher 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al</AU>
<TI>Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>352</VL>
<NO>9128</NO>
<PG>609-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Newell-1992" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Newell 1992" TYPE="JOURNAL_ARTICLE">
<AU>Newell DJ</AU>
<TI>Intention-to-treat analysis: implications for quantitative and qualitative research</TI>
<SO>International Journal of Epidemiology</SO>
<YR>1992</YR>
<VL>21</VL>
<NO>5</NO>
<PG>837-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2008" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="RevMan 2008" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2008</YR>
<PB>Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Royle-2003" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Royle 2003" NOTES="&lt;p&gt;'International Journal of Technology Assessment in Health Care' 2003;19:4:591-603 with a title 'Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches' by Royle P et al.&lt;/p&gt;" NOTES_MODIFIED="2008-10-27 16:38:37 +0100" NOTES_MODIFIED_BY="dimitrinka nikolova" TYPE="JOURNAL_ARTICLE">
<AU>Royle P, Milne R</AU>
<TI>Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches</TI>
<SO>International Journal of Technology Assessment in Health Care</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>4</NO>
<PG>591-603</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rui-2003" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Rui 2003" TYPE="JOURNAL_ARTICLE">
<AU>Rui JA, Wang SB, Chen SG, Zhou L</AU>
<TI>Right trisectionectomy for primary liver cancer</TI>
<SO>World Journal of Gastroenterology</SO>
<YR>2003</YR>
<VL>9</VL>
<NO>4</NO>
<PG>706-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<NO>5</NO>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shimada-1998" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Shimada 1998" TYPE="JOURNAL_ARTICLE">
<AU>Shimada M, Takenaka K, Fujiwara Y, Gion T, Shirabe K, Yanaga K, et al</AU>
<TI>Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma</TI>
<SO>British Journal of Surgery</SO>
<YR>1998</YR>
<VL>85</VL>
<NO>2</NO>
<PG>195-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smyrniotis-2002" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Smyrniotis 2002" TYPE="JOURNAL_ARTICLE">
<AU>Smyrniotis VE, Kostopanagiotou GG, Gamaletsos EL, Vassiliou JG, Voros DC, Fotopoulos AC, et al</AU>
<TI>Total versus selective hepatic vascular exclusion in major liver resections</TI>
<SO>American Journal of Surgery</SO>
<YR>2002</YR>
<VL>183</VL>
<NO>2</NO>
<PG>173-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Strasberg-2000" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Strasberg 2000" TYPE="JOURNAL_ARTICLE">
<AU>Strasberg SM, Belghiti J, Clavien PA, Gadzijev E, Garden JO, Lau WY, et al</AU>
<TI>The Brisbane 2000 terminology of liver anatomy and resections</TI>
<SO>HPB Surgery</SO>
<YR>2000</YR>
<VL>2</VL>
<NO>3</NO>
<PG>333-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sweeting-2004" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Sweeting 2004" TYPE="JOURNAL_ARTICLE">
<AU>Sweeting MJ, Sutton AJ, Lambert PC</AU>
<TI>What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data</TI>
<SO>Statistics in Medicine</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>9</NO>
<PG>1351-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wang-2006" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Wang 2006" TYPE="JOURNAL_ARTICLE">
<AU>Wang WD, Liang LJ, Huang XQ, Yin XY</AU>
<TI>Low central venous pressure reduces blood loss in hepatectomy</TI>
<SO>World Journal of Gastroenterology</SO>
<YR>2006</YR>
<VL>12</VL>
<NO>6</NO>
<PG>935-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weber-2002" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Weber 2002" TYPE="JOURNAL_ARTICLE">
<AU>Weber JC, Navarra G, Jiao LR, Nicholls JP, Jensen SL, Habib NA</AU>
<TI>New technique for liver resection using heat coagulative necrosis</TI>
<SO>Annals of Surgery</SO>
<YR>2002</YR>
<VL>236</VL>
<NO>5</NO>
<PG>560-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wood-2008" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Wood 2008" TYPE="JOURNAL_ARTICLE">
<AU>Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al</AU>
<TI>Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study</TI>
<SO>BMJ (Clinical Research Ed.)</SO>
<YR>2008</YR>
<VL>336</VL>
<PG>601-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yoshimura-2004" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Yoshimura 2004" TYPE="JOURNAL_ARTICLE">
<AU>Yoshimura Y, Kubo S, Shirata K, Hirohashi K, Tanaka H, Shuto T, et al</AU>
<TI>Risk factors for postoperative delirium after liver resection for hepatocellular carcinoma</TI>
<SO>World Journal of Surgery</SO>
<YR>2004</YR>
<VL>28</VL>
<NO>10</NO>
<PG>982-6</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2008-09-27 18:27:50 +0100" MODIFIED_BY="Kurinchi S Gurusamy"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-09-29 10:19:23 +0100" MODIFIED_BY="dimitrinka nikolova">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-09-29 10:19:23 +0100" MODIFIED_BY="dimitrinka nikolova" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" STUDY_ID="STD-Arita-2005">
<CHAR_METHODS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Randomised clinical trial.</P>
<P>Generation of the allocation sequence: computerised minimisation process (adequate).<BR/>Allocation concealment: held by third party (adequate).<BR/>Blinding: inadequate.<BR/>Incomplete outcome data addressed:adequate.<BR/>Free from selective reporting: adequate.<BR/>Free from baseline imbalance bias: adequate.<BR/>Free from early stopping bias: adequate.<BR/>Free from sponsor bias: adequate.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Country: Japan.<BR/>Number randomised: 80.<BR/>Median age: 66 (RFDS); 68 (clamp-crush).<BR/>Females: 20 (25%).<BR/>Major liver resection: 20 (25%).<BR/>Chronic liver disease: 43 (53.8%).<BR/>Cirrhosis: 21 (26.3%).</P>
<P>Inclusion criteria</P>
<OL>
<LI>Hepatic resection for hepatobiliary malignancy.</LI>
<LI>Age 20 to 79 years.</LI>
<LI>Platelet count more than 50000/ml.</LI>
<LI>Prothrombin activity &gt; 60% .</LI>
<LI>Bleeding time &lt; 5 min.</LI>
</OL>
<P>Exclusion criteria</P>
<P>Inflow occlusion at the hepatic hilum proved impossible at laparotomy.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Participants were randomly assigned to two groups.</P>
<P>Group 1: RFDS (n = 40)<BR/>Group 2: Clamp-crush (n = 40).</P>
<P>Co-interventions</P>
<OL>
<LI>Vascular occlusion: intermittent PTC (15min +5 min) or hemihepatic vascular occlusion (30min + 5 min).</LI>
<LI>Low CVP: not stated.</LI>
<LI>Hypoventilation: not stated.</LI>
<LI>IV agents to decrease blood loss: not stated.</LI>
<LI>Management of raw surface: vessels larger than 1 mm in diameter were ligated and divided. Small vessels and minor oozing were dealt with by cauterization. Macroscopic bile leakage - controlled by fine suturing; fibrin glue.</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The main outcome measures were peri-operative mortality, peri-operative morbidity, blood loss and transfusion requirements, liver function tests, transection speed, and hospital stay.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>We requested further information from the authors regarding some outcomes in December 2006. We were unable to obtain the information. </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-09-29 10:19:23 +0100" MODIFIED_BY="dimitrinka nikolova" STUDY_ID="STD-Koo-2005">
<CHAR_METHODS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Randomised clinical trial.</P>
<P>Generation of the allocation sequence: unclear.<BR/>Allocation concealment: unclear.<BR/>Blinding: inadequate.<BR/>Incomplete outcome data addressed:adequate.<BR/>Free from selective reporting: inadequate.<BR/>Free from baseline imbalance bias: adequate.<BR/>Free from early stopping bias: unclear.<BR/>Free from blocked randomisation bias: unclear.<BR/>Free from sponsor bias: unclear.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-09-29 10:19:23 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Country: Korea.<BR/>Number randomised: 50.<BR/>Mean age: 52.7 years.<BR/>Females: 14 (28%).<BR/>Major liver resection: not stated.<BR/>Chronic liver disease: not stated.<BR/>Cirrhosis: not stated.</P>
<P>Inclusion criteria</P>
<P>Elective liver resection.</P>
<P>Exclusion criteria</P>
<OL>
<LI>Cardiopulmonary diseases.</LI>
<LI>Patients with dysphagia, hiatal hernia, or oesophageal disease.</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Participants were randomly assigned to two groups.</P>
<P>Group 1: CUSA (n = 25)<BR/>Group 2: Clamp-crush (n = 25).</P>
<P>Co-interventions</P>
<OL>
<LI>Vascular occlusion: no vascular occlusion.</LI>
<LI>Low CVP: no.</LI>
<LI>Hypoventilation: not stated.</LI>
<LI>IV agents to decrease blood loss: not stated.</LI>
<LI>Management of raw surface: not stated.</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The main outcome measures were peri-operative morbidity, blood loss and transfusion requirements, transection time, and operating time.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>We requested further information from the authors regarding some outcomes in December 2006. We were unable to obtain the information.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" STUDY_ID="STD-Lesurtel-2005">
<CHAR_METHODS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Randomised clinical trial.</P>
<P>Generation of the allocation sequence: urn randomisation (adequate).<BR/>Allocation concealment: sealed envelope (adequate).<BR/>Blinding: inadequate.<BR/>Incomplete outcome data addressed:adequate.<BR/>Free from selective reporting: adequate.<BR/>Free from baseline imbalance bias: adequate.<BR/>Free from early stopping bias: adequate.Free from sponsor bias: inadequate.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Country: Switzerland.<BR/>Number randomised: 100.<BR/>Mean age: 56 years.<BR/>Females: 47(47%).<BR/>Major liver resection: 61(61%).<BR/>Chronic liver disease: not stated.<BR/>Cirrhosis: none.</P>
<P>Inclusion criteria</P>
<OL>
<LI>&gt; 2 segments</LI>
<LI>Benign or malignant tumours</LI>
<LI>Platelet count &gt; 100000/ml.</LI>
<LI>Prothrombin activity &gt;60%.</LI>
</OL>
<P>Exclusion criteria</P>
<OL>
<LI>Cirrhotic.</LI>
<LI>Cholestatic (serum bilirubin &gt; 100 mumol/L).</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Participants were randomly assigned to four groups.</P>
<P>Group 1: CUSA (n = 25)<BR/>Group 2: Hydrojet (n = 25)<BR/>Group 3: RFDS (n = 25)<BR/>Group 4: Clamp-crush (n = 25).</P>
<P>Co-interventions</P>
<OL>
<LI>Vascular occlusion: no inflow occlusion unless significant bleeding preventing selective coagulation or ligation of small structures. In the clamp-crush group, PTC was used routinely.</LI>
<LI>Low CVP: yes (0-5mmHg).</LI>
<LI>Hypoventilation: not stated.</LI>
<LI>IV agents to decrease blood loss: not stated.</LI>
<LI>Management of raw surface: &lt; 2 mm coagulated, bigger vessels, bile ducts ligated.</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The main outcome measures were peri-operative mortality, peri-operative morbidity, blood loss and transfusion requirements, liver function tests, transection speed, stay, and costs.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Authors provided information on allocation sequence generation; and questions related to morbidity and liver enzymes in December 2006.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" STUDY_ID="STD-Lupo-2007">
<CHAR_METHODS MODIFIED="2008-09-26 14:47:34 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Randomised clinical trial.</P>
<P>Generation of the allocation sequence: random number table (adequate).<BR/>Allocation concealment: unclear.<BR/>Blinding: inadequate.<BR/>Incomplete outcome data addressed:adequate.<BR/>Free from selective reporting: adequate.<BR/>Free from baseline imbalance bias: adequate.<BR/>Free from early stopping bias: adequate.<BR/>Free from sponsor bias: adequate.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Country: Italy.<BR/>Number randomised: 51 (1 did not undergo resection because of advanced malignancy noted only during malignancy).<BR/>Median age: 62<BR/>Females: 14 (28%).<BR/>Major liver resection: 21 (42%).<BR/>Chronic liver disease: not stated.<BR/>Cirrhosis: 7 (14%).</P>
<P>Inclusion criteria<BR/>Curative liver resection for primary or secondary liver cancer.</P>
<P>Exclusion criteria<BR/>Patients not considered eligible for radical treatment after laparotomy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Participants were randomly assigned to two groups.</P>
<P>Group 1: RFDS (n = 24)<BR/>Group 2: Clamp-crush (n = 26).</P>
<P>Co-interventions</P>
<OL>
<LI>Vascular occlusion: no vascular occlusion.</LI>
<LI>Low CVP: not stated.</LI>
<LI>Hypoventilation: not stated.</LI>
<LI>IV agents to decrease blood loss: not stated.</LI>
<LI>Management of raw surface: RFDS group - sealing of large vessels was reinforced with stitches. Clamp-crush group - bipolar diathermy and 3-0 prolene sutures. Fibrin glue was used in some patients.</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The main outcome measures were peri-operative mortality, peri-operative morbidity, transfusion requirements, operating time, and hospital stay.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The trial authors provided information on allocation concealment and location of abscesses in March 2008.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" STUDY_ID="STD-Rau-2001">
<CHAR_METHODS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Randomised clinical trial.</P>
<P>Generation of the allocation sequence: lots (adequate).<BR/>Allocation concealment: unclear.<BR/>Blinding: inadequate.<BR/>Incomplete outcome data addressed:adequate.<BR/>Free from selective reporting: inadequate.<BR/>Free from baseline imbalance bias: adequate.<BR/>Free from early stopping bias: unclear.<BR/>Free from sponsor bias: unclear.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-09-26 14:47:51 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Country: Germany.<BR/>Number randomised: 61.<BR/>Mean age: 62.3 years.<BR/>Females: 25 (41.0%).<BR/>Major liver resection: 24 (39.3%).<BR/>Chronic liver disease: Not stated.<BR/>Cirrhosis: Not stated.</P>
<P>Inclusion criteria</P>
<OL>
<LI>Hepatic resection.</LI>
<LI>Child A liver function.</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Participants were randomly assigned to two groups.</P>
<P>Group 1: Waterjet (n = 31)<BR/>Group 2: CUSA (n = 30).</P>
<P>Co-interventions</P>
<OL>
<LI>Vascular occlusion: Pringle.</LI>
<LI>Low CVP: not stated.</LI>
<LI>Hypoventilation: not stated.</LI>
<LI>IV agents to decrease blood loss: not stated.</LI>
<LI>Management of raw surface: Fibrin glue.</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The main outcome measures were blood loss and transfusion requirements, and transection speed.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>Authors provided information on allocation sequence generation and allocation concealment in March 2007.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" STUDY_ID="STD-Smyrniotis-2005">
<CHAR_METHODS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Randomised clinical trial.</P>
<P>Generation of the allocation sequence: unclear.<BR/>Allocation concealment: unclear.<BR/>Blinding: inadequate.<BR/>Incomplete outcome data addressed:adequate.<BR/>Free from selective reporting: adequate.<BR/>Free from baseline imbalance bias: adequate.<BR/>Free from early stopping bias: adequate.<BR/>Free from sponsor bias: unclear.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Country: Greece.<BR/>Number randomised: 82.<BR/>Median age: 63 years.<BR/>Females: 17 (28%).<BR/>Major liver resection: 60 (73%).<BR/>Chronic liver disease: not stated.<BR/>Cirrhosis: 12 (14.6%).</P>
<P>Inclusion criteria<BR/>Liver resection for benign or malignant conditions.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Participants were randomly assigned to two groups.</P>
<P>Group 1: Sharp transection (n = 41)<BR/>Group 2: Clamp-crush (n = 41).</P>
<P>Co-interventions</P>
<OL>
<LI>Vascular occlusion: Selective HVE - last 50 patients (25 in each group) - IPC (10 minutes occlusion followed by 10 minutes reperfusion before vascular occlusion).</LI>
<LI>Low CVP: not stated.</LI>
<LI>Hypoventilation: not stated.</LI>
<LI>IV agents to decrease blood loss: not stated.</LI>
<LI>Management of raw surface: visible vessels and Biliary ducts - ligated with poly-propylene 3-0 or 4-0; residual bleeding - argon coagulator.</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The main outcome measures were peri-operative mortality, peri-operative morbidity, blood loss and transfusion requirements, operating time, and stay.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The authors provided information on allocation concealment and morbidity in December 2006.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" STUDY_ID="STD-Takayama-2001">
<CHAR_METHODS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Randomised clinical trial.</P>
<P>Generation of the allocation sequence: computerised minimisation process (adequate).<BR/>Allocation concealment: held by third party (adequate).<BR/>Blinding: inadequate.<BR/>Incomplete outcome data addressed:adequate.<BR/>Free from selective reporting: adequate.<BR/>Free from baseline imbalance bias: adequate.<BR/>Free from early stopping bias: adequate.<BR/>Free from sponsor bias: adequate.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Country: Japan.<BR/>Number randomised: 132.<BR/>Median age: 61 years (group 1); 63 years (group 2).<BR/>Females: Not stated.<BR/>Major liver resection: 43 (32.6%).<BR/>Chronic liver disease: not stated.<BR/>Cirrhosis: not stated.</P>
<P>Inclusion criteria</P>
<OL>
<LI>Partial hepatectomy for tumor resection or graft harvest.</LI>
<LI>Hepatic function of Child-Pugh class A or B.</LI>
<LI>Platelet count &gt; 50000/ml.</LI>
<LI>Prothrombin activity &gt; 60%.</LI>
<LI>Adequate functional reserve of the heart, lungs, and kidneys.</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<P>Participants were randomly assigned to two groups.</P>
<P>Group 1: CUSA (n = 66)<BR/>Group 2: Clamp-crush (n = 66).</P>
<P>Co-interventions</P>
<OL>
<LI>Vascular occlusion: PTC intermittent - 15min+5 min; Selective - 30min + 5min.</LI>
<LI>Low CVP: no.</LI>
<LI>Hypoventilation: not stated.</LI>
<LI>IV agents to decrease blood loss: not stated.</LI>
<LI>Management of raw surface: tiny vessels cauterized; &gt; 1mm ligated; bleeding or bile leak points - sutured; Fibrin glue applied.</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The main outcome measures were peri-operative mortality, peri-operative morbidity, blood loss and transfusion requirements, and transection speed.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>The authors provided information on randomisation procedure and morbidity in January 2007.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ALT = alanine transaminase<BR/>AST = aspartate transaminase<BR/>CUSA = cavitron ultrasonic surgical aspirator<BR/>CVP = central venous pressure<BR/>HVE = hepatic vascular exclusion<BR/>IPC = ischaemic pre-conditioning<BR/>ITU = intensive therapy unit<BR/>IV = intravenous<BR/>PTC = portal triad clamping<BR/>RFDS = radiofrequency dissection sealer</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Rau-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomisation was stopped because of technical difficulties.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2008-08-25 13:04:54 +0100" MODIFIED_BY="dimitrinka nikolova" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Arita-2005">
<DESCRIPTION>
<P>A - Adequate ("The assignments were done by an internet-accessed registration system administered by the independent randomization service")</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="UNKNOWN" STUDY_ID="STD-Koo-2005">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Lesurtel-2005">
<DESCRIPTION>
<P>A - Adequate ("The generation of the randomisation sequence was performed with sealed envelopes using urn randomisation")</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Lupo-2007">
<DESCRIPTION>
<P>A - Adequate ("The allocation was performed by random numbers tables with sealed envelopes").</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Rau-2001">
<DESCRIPTION>
<P>A - Adequate ("The selection of letters was performed by the leading nurse of the operation theatre")</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="UNKNOWN" STUDY_ID="STD-Smyrniotis-2005">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-25 13:04:54 +0100" MODIFIED_BY="dimitrinka nikolova" RESULT="YES" STUDY_ID="STD-Takayama-2001">
<DESCRIPTION>
<P>A - Adequate ("The randomisation was generated by the minimization method using Microsoft Excel (for Windows) and its Visual Basic").</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2008-08-25 13:04:56 +0100" MODIFIED_BY="dimitrinka nikolova" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Arita-2005">
<DESCRIPTION>
<P>A - Adequate ("The assignments were done by an internet-accessed registration system administered by the independent randomization service")</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="UNKNOWN" STUDY_ID="STD-Koo-2005">
<DESCRIPTION>
<P>B - Unclear ("Randomization was performed by opening a sealed envelope before induction of anesthesia"). However, it was not clear whether randomisation was performed in blocks.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Lesurtel-2005">
<DESCRIPTION>
<P>A - Adequate ("The generation of the randomisation sequence was performed with sealed envelopes using urn randomisation")</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="UNKNOWN" STUDY_ID="STD-Lupo-2007">
<DESCRIPTION>
<P>B - Unclear ("The allocation was performed by random numbers tables with sealed envelopes"). However, it was not clear if randomisation was performed using blocks.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="UNKNOWN" STUDY_ID="STD-Rau-2001">
<DESCRIPTION>
<P>B - Unclear ("when the decision for liver resection was made, the letter was opened with the information on the dissection device"). However, it was not clear whether randomisation was performed in blocks. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="UNKNOWN" STUDY_ID="STD-Smyrniotis-2005">
<DESCRIPTION>
<P>B - Unclear ("Patients were randomized in the operating room using sealed envelopes"). However, it was not clear whether randomisation was performed in blocks.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-25 13:04:56 +0100" MODIFIED_BY="dimitrinka nikolova" RESULT="YES" STUDY_ID="STD-Takayama-2001">
<DESCRIPTION>
<P>A - Adequate ("The randomisation was generated by the minimization method using Microsoft Excel (for Windows) and its Visual Basic").</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="NO" STUDY_ID="STD-Arita-2005">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="NO" STUDY_ID="STD-Koo-2005">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="NO" STUDY_ID="STD-Lesurtel-2005">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="NO" STUDY_ID="STD-Lupo-2007">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="NO" STUDY_ID="STD-Rau-2001">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="NO" STUDY_ID="STD-Smyrniotis-2005">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="NO" STUDY_ID="STD-Takayama-2001">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Arita-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review authors' comment: No post-randomisation drop-outs.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Koo-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review authors' comment: No post-randomisation drop-outs.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Lesurtel-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review authors' comment: No post-randomisation drop-outs.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Lupo-2007">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review authors' comment: One patient who allocated to RFDS group had advanced cancer on laparotomy and did not receive the intervention. However, we think that this post-randomisation drop-out was not related to the outcomes. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Rau-2001">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review authors' comment: No post-randomisation drop-outs.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Smyrniotis-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review authors' comment: No post-randomisation drop-outs.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Takayama-2001">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review authors' comment: No post-randomisation drop-outs.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Arita-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review authors' comment: All the important outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="NO" STUDY_ID="STD-Koo-2005">
<DESCRIPTION>
<P>C - Inadequate</P>
<P>Review authors' comment: Important outcomes were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Lesurtel-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review authors' comment: All the important outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Lupo-2007">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review authors' comment: All the important outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="NO" STUDY_ID="STD-Rau-2001">
<DESCRIPTION>
<P>C - Inadequate</P>
<P>Review authors' comment: Important outcomes were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Smyrniotis-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review authors' comment: All the important outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Takayama-2001">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review authors' comment: All the important outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="7">
<NAME>Free of baseline imbalance bias?</NAME>
<DESCRIPTION>
<P>Were the two groups well matched for important characterisitics?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Arita-2005">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Koo-2005">
<DESCRIPTION>
<P>A - Adequate ("Differences in the demographic data and duration of surgery between groups were not significant")</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Lesurtel-2005">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Lupo-2007">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Rau-2001">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Smyrniotis-2005">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Takayama-2001">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="8">
<NAME>From from early stopping bias?</NAME>
<DESCRIPTION>
<P>Was the trial stopped before the recruitment of the intended number of patients?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Arita-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review author comment: The sample size calculations were reported and the calculated number of patients were recruited.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="UNKNOWN" STUDY_ID="STD-Koo-2005">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Lesurtel-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review author comment: The sample size calculations were reported and the calculated number of patients were recruited.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Lupo-2007">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review author comment: The sample size calculations were reported and the calculated number of patients were recruited.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="UNKNOWN" STUDY_ID="STD-Rau-2001">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Smyrniotis-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review author comment: The sample size calculations were reported and the calculated number of patients were recruited.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Takayama-2001">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review author comment: The sample size calculations were reported and the calculated number of patients were recruited.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" NO="9">
<NAME>Free from academic bias?</NAME>
<DESCRIPTION>
<P>Has the author performed a similar trial before comparing the same intervention?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" RESULT="YES" STUDY_ID="STD-Arita-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review author comment: No previous publication or conference report of a similar trial by the trial author was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" RESULT="YES" STUDY_ID="STD-Koo-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review author comment: No previous publication or conference report of a similar trial by the trial author was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" RESULT="YES" STUDY_ID="STD-Lesurtel-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review author comment: No previous publication or conference report of a similar trial by the trial author was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" RESULT="YES" STUDY_ID="STD-Lupo-2007">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review author comment: No previous publication or conference report of a similar trial by the trial author was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" RESULT="YES" STUDY_ID="STD-Rau-2001">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review author comment: No previous publication or conference report of a similar trial by the trial author was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" RESULT="YES" STUDY_ID="STD-Smyrniotis-2005">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review author comment: No previous publication or conference report of a similar trial by the trial author was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-29 10:17:04 +0100" MODIFIED_BY="dimitrinka nikolova" RESULT="YES" STUDY_ID="STD-Takayama-2001">
<DESCRIPTION>
<P>A - Adequate</P>
<P>Review author comment: No previous publication or conference report of a similar trial by the trial author was identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="10">
<NAME>Free from sponsor bias?</NAME>
<DESCRIPTION>
<P>Could the reporting of the trial results influenced by the sponsor funding the trial?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Arita-2005">
<DESCRIPTION>
<P>A - Adequate ("This work was supported by a grant from the Kanae Foundation for Life-Socio-medical service")</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="UNKNOWN" STUDY_ID="STD-Koo-2005">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="NO" STUDY_ID="STD-Lesurtel-2005">
<DESCRIPTION>
<P>C - Inadequate ("The authors thank Tyco Healthcare (Mansfield, MA), Erbe (Tubingen, Germany), and TissueLink (Dover, NH) for their sponsorship")</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Lupo-2007">
<DESCRIPTION>
<P>A - Adequate ("The authors thank the Hospital Service Spa (Aprilia) for helping with the technical development of the devices used")</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="UNKNOWN" STUDY_ID="STD-Rau-2001">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="UNKNOWN" STUDY_ID="STD-Smyrniotis-2005">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-09 19:50:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" RESULT="YES" STUDY_ID="STD-Takayama-2001">
<DESCRIPTION>
<P>A - Adequate ("This work was supported in part by a grant-in-aid for cancer research from the Ministiy of Health and Welfare, Tokyo, Japan")<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NO="1">
<TITLE MODIFIED="2008-07-09 19:55:18 +0100" MODIFIED_BY="Kurinchi S Gurusamy">Radiofrequency dissecting sealer versus clamp-crush</TITLE>
<TABLE COLS="5" ROWS="20">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Outcome</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Number of studies</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Number of patients</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Meta-analysis</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Other trials</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Peri-operative mortality</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>180</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liver failure</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>100</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.74 [0.14, 3.95]<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bleeding requiring percutaneous drainage</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bile leak requiring operation</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>130</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.69 [0.22, 13.15]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bile leak requiring percutaneous drainage</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>130</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.70 [0.13, 3.73]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Biliary fistula</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8.63 [0.42, 176.32]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Infected abdominal collections</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>130</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11.02 [1.38, 88.28]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Wound infection</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7.58 [0.84, 68.46]<BR/>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Transection blood loss (ml/sq cm)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.90 [0.92, 2.88]<BR/>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Blood transfused (units)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<BR/>1.5 units vs 0 units (<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Number requiring transfusion</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>180</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.19 [0.50, 2.82]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Peak bilirubin (mumol/litre)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.00 [-19.40, 19.40]<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Peak prothrombin activity (percentage of activity)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.00 [-25.66, 27.66]<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Aspartate transaminase (AST) and alanine transaminase (ALT)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No difference (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Transection speed (sq cm/minute)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-1.40 [-2.23, -0.57]<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Operating time (minutes)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>292 vs 278 (<LINK REF="STD-Lupo-2007" TYPE="STUDY">Lupo 2007</LINK>)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Intensive therapy unit stay (days)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 vs 1 median (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Hospital stay (days)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>100</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 vs 9 median (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>)</P>
<P>16 vs 18 median (<LINK REF="STD-Arita-2005" TYPE="STUDY">Arita 2005</LINK>)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Costs (Euros per patient)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>not applicable</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1618 vs 497 <LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>
<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>cm = centimetre<BR/>ml = millilitre<BR/>mumol = micromole<BR/>sq = square<BR/>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NO="2">
<TITLE MODIFIED="2008-07-09 19:56:26 +0100" MODIFIED_BY="Kurinchi S Gurusamy">Hydrojet versus cavitron ultrasonic surgical aspirator</TITLE>
<TABLE COLS="5" ROWS="19">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Outcome</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Number of studies</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Number of patients</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Meta-analysis</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Other studies</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Peri-operative mortality</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.00 [0.13, 7.72]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Liver failure</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.00 [0.06, 16.93]<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bleeding requiring percutaneous drainage</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.12 [0.12, 80.39]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bile leak requiring intervention</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.32 [0.01, 8.25]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Wound infection</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Operative blood loss (ml)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>61</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-318.00 [-3094.03, 2458.03]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Transection blood loss (ml/sq)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-0.50 [-2.19, 1.19]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean blood transfusion requirements</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>61</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-0.10 [-0.60, 0.41]<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Number requiring transfusion</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.00 [0.30, 3.28]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Peak bilirubin (mumol/litre)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18.00 [-2.83, 38.83]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Peak prothrombin activity (percentage of activity)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-3.00 [-14.09, 8.09]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Aspartate transaminase (AST) and alanine transaminase (ALT)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No difference (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Operating time (minutes)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-27.30 [-58.63, 4.03]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Transection time (minutes)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>61</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-18.00 [-61.03, 25.03]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Transection speed (sq cm/minute)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>111</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.01 [-0.36, 0.38]<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Intensive therapy unit stay (days)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 vs 1 median (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Hospital stay (days)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 vs 9 median (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Costs (Euros per patient)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>not applicable</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1125 to 2235 vs 1587 to 2912 (depending upon the volume) (<LINK REF="STD-Lesurtel-2005" TYPE="STUDY">Lesurtel 2005</LINK>)<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>cm = centimetre<BR/>ml = millilitre<BR/>mumol = micromole<BR/>sq = square</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-09-27 17:14:05 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<COMPARISON ID="CMP-001" MODIFIED="2008-09-16 15:31:02 +0100" MODIFIED_BY="dimitrinka nikolova" NO="1">
<NAME>CUSA versus clamp-crush</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="66" TOTAL_2="66" WEIGHT="0.0" Z="0.0">
<NAME>Peri-operative mortality</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1" O_E="0.0" SE="0.0" STUDY_ID="STD-Takayama-2001" TOTAL_1="66" TOTAL_2="66" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Air embolism (clinical)</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="2" O_E="0.0" SE="0.0" STUDY_ID="STD-Koo-2005" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.907620924971573E-32" CI_END="457.61406473970567" CI_START="1.3409196105421741" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="24.77142857142857" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="17" I2="100.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="2.6604993640038805" LOG_CI_START="0.12740274224798856" LOG_EFFECT_SIZE="1.3939510531259347" METHOD="MH" MODIFIED="2008-09-16 15:31:02 +0100" MODIFIED_BY="dimitrinka nikolova" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.030996489836808392" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="2.157117763983814">
<NAME>Air embolism (Echocardiogram)</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="457.6140647397061" CI_START="1.3409196105421748" EFFECT_SIZE="24.771428571428572" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="17" LOG_CI_END="2.660499364003881" LOG_CI_START="0.12740274224798878" LOG_EFFECT_SIZE="1.3939510531259347" ORDER="3" O_E="0.0" SE="1.4879534946499156" STUDY_ID="STD-Koo-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.214005602240896" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="66" TOTAL_2="66" WEIGHT="0.0" Z="0.0">
<NAME>Bile leak requiring intervention</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="4" O_E="0.0" SE="0.0" STUDY_ID="STD-Takayama-2001" TOTAL_1="66" TOTAL_2="66" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="22.96089796892525" CI_START="0.1796957840274367" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="2.03125" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="1.3609888687138807" LOG_CI_START="-0.7454621120679813" LOG_EFFECT_SIZE="0.3077633783229496" METHOD="MH" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.5668331167652148" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="66" TOTAL_2="66" WEIGHT="100.0" Z="0.5727217417131272">
<NAME>Abdominal collections requiring drainage</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="22.96089796892525" CI_START="0.1796957840274367" EFFECT_SIZE="2.03125" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3609888687138807" LOG_CI_START="-0.7454621120679813" LOG_EFFECT_SIZE="0.3077633783229496" ORDER="5" O_E="0.0" SE="1.2373397332117866" STUDY_ID="STD-Takayama-2001" TOTAL_1="66" TOTAL_2="66" VAR="1.5310096153846153" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="22.96089796892525" CI_START="0.1796957840274367" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="2.03125" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="1.3609888687138807" LOG_CI_START="-0.7454621120679813" LOG_EFFECT_SIZE="0.3077633783229496" METHOD="MH" NO="6" P_CHI2="1.0" P_Q="0.0" P_Z="0.5668331167652148" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="66" TOTAL_2="66" WEIGHT="100.0" Z="0.5727217417131272">
<NAME>Infected abdominal collections</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="22.96089796892525" CI_START="0.1796957840274367" EFFECT_SIZE="2.03125" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3609888687138807" LOG_CI_START="-0.7454621120679813" LOG_EFFECT_SIZE="0.3077633783229496" ORDER="6" O_E="0.0" SE="1.2373397332117866" STUDY_ID="STD-Takayama-2001" TOTAL_1="66" TOTAL_2="66" VAR="1.5310096153846153" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="16.330717844801725" CI_START="0.061234295363097754" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="1.213005275317456" LOG_CI_START="-1.213005275317456" LOG_EFFECT_SIZE="0.0" METHOD="MH" NO="7" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="66" TOTAL_2="66" WEIGHT="100.0" Z="0.0">
<NAME>Wound infection</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="16.330717844801725" CI_START="0.061234295363097754" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.213005275317456" LOG_CI_START="-1.213005275317456" LOG_EFFECT_SIZE="0.0" ORDER="7" O_E="0.0" SE="1.4250506063888506" STUDY_ID="STD-Takayama-2001" TOTAL_1="66" TOTAL_2="66" VAR="2.0307692307692307" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="214.4336644462319" CI_START="-381.83366444623175" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-83.69999999999993" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.08" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.5821457613513162" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="0.5502531416930561">
<NAME>Operative blood loss (ml)</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="214.4336644462319" CI_START="-381.83366444623175" EFFECT_SIZE="-83.69999999999993" ESTIMABLE="YES" MEAN_1="791.7" MEAN_2="875.4" ORDER="8" SD_1="494.1" SD_2="578.2" SE="152.1118075627267" STUDY_ID="STD-Koo-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="50.10680052834269" CI_START="-216.30680052834268" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-83.1" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.09" NO="9" P_CHI2="1.0" P_Q="1.0" P_Z="0.22144006564040164" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="1.222707898315024">
<NAME>Blood transfused (ml)</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="50.10680052834269" CI_START="-216.30680052834268" EFFECT_SIZE="-83.1" ESTIMABLE="YES" MEAN_1="117.6" MEAN_2="200.7" ORDER="9" SD_1="108.3" SD_2="322.1" SE="67.96390218343853" STUDY_ID="STD-Koo-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="4.034939143916461" CI_START="-58.63493914391643" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-27.299999999999983" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.10" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.08771370117770642" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="1.707583235831228">
<NAME>Operating time (minutes)</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.034939143916461" CI_START="-58.63493914391643" EFFECT_SIZE="-27.299999999999983" ESTIMABLE="YES" MEAN_1="231.4" MEAN_2="258.7" ORDER="10" SD_1="66.0" SD_2="45.1" SE="15.987507623141264" STUDY_ID="STD-Koo-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="18.65157792533578" CI_START="-60.65157792533575" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-20.999999999999986" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.11" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.29925943491529305" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="1.0380228437023185">
<NAME>Transection time (minutes)</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="18.65157792533578" CI_START="-60.65157792533575" EFFECT_SIZE="-20.999999999999986" ESTIMABLE="YES" MEAN_1="118.7" MEAN_2="139.7" ORDER="11" SD_1="78.9" SD_2="63.3" SE="20.230768645802858" STUDY_ID="STD-Koo-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="12.852908474334114" CI_START="0.8554063740319771" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="3.315789473684211" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="1.1090014149378544" LOG_CI_START="-0.06782751793634885" LOG_EFFECT_SIZE="0.5205869485007528" METHOD="MH" NO="12" P_CHI2="1.0" P_Q="0.0" P_Z="0.08291175547829452" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="66" TOTAL_2="66" WEIGHT="100.0" Z="1.7340356637750194">
<NAME>Tumour exposure at resection margin</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="12.852908474334114" CI_START="0.8554063740319771" EFFECT_SIZE="3.3157894736842106" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="3" LOG_CI_END="1.1090014149378544" LOG_CI_START="-0.06782751793634885" LOG_EFFECT_SIZE="0.5205869485007527" ORDER="12" O_E="0.0" SE="0.6912751405674755" STUDY_ID="STD-Takayama-2001" TOTAL_1="66" TOTAL_2="66" VAR="0.4778613199665831" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2008-06-30 17:45:58 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="2">
<NAME>CUSA versus clamp-crush with vascular occlusion</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="118.95804526560195" CI_START="0.24745191881562512" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="5.425531914893617" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="2.075393819187927" LOG_CI_START="-0.6065091741914517" LOG_EFFECT_SIZE="0.7344423224982377" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.28305719878385516" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="1.0734769336340946">
<NAME>Peri-operative mortality</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="118.95804526560195" CI_START="0.24745191881562512" EFFECT_SIZE="5.425531914893617" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.075393819187927" LOG_CI_START="-0.6065091741914517" LOG_EFFECT_SIZE="0.7344423224982377" ORDER="13" O_E="0.0" SE="1.575363093944971" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.4817688777638716" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="16.927920091810748" CI_START="0.059074002864874804" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="1.2286036002743048" LOG_CI_START="-1.2286036002743048" LOG_EFFECT_SIZE="0.0" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.0">
<NAME>Liver failure</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="16.927920091810748" CI_START="0.059074002864874804" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2286036002743048" LOG_CI_START="-1.2286036002743048" LOG_EFFECT_SIZE="0.0" ORDER="14" O_E="0.0" SE="1.4433756729740645" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.0833333333333335" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Bleeding requiring percutaneous drainage</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="15" O_E="0.0" SE="0.0" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.651593953590669" CI_START="0.0406258298685047" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.4791666666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.7521709518230808" LOG_CI_START="-1.3911977545390697" LOG_EFFECT_SIZE="-0.31951340135799433" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.5589873678720993" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.5843462745170355">
<NAME>Bile leak requiring percutaneous drainage</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.651593953590671" CI_START="0.0406258298685047" EFFECT_SIZE="0.4791666666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.752170951823081" LOG_CI_START="-1.3911977545390697" LOG_EFFECT_SIZE="-0.31951340135799433" ORDER="16" O_E="0.0" SE="1.2590253879633373" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="1.585144927536232" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.245465728677031" CI_START="0.012439247458696873" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.3202614379084967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.9162151909304671" LOG_CI_START="-1.9052058925086373" LOG_EFFECT_SIZE="-0.4944953507890852" METHOD="MH" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.4920671273830989" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.6870247647598438">
<NAME>Wound infection</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.245465728677027" CI_START="0.012439247458696873" EFFECT_SIZE="0.3202614379084967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9162151909304669" LOG_CI_START="-1.9052058925086373" LOG_EFFECT_SIZE="-0.4944953507890852" ORDER="17" O_E="0.0" SE="1.6573167106717377" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.7466986794717885" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="3.9926641001922007" CI_START="1.007335899807799" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.0010283231106585596" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="3.282660821493064">
<NAME>Transection blood loss (ml/sq cm)</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.9926641001922007" CI_START="1.007335899807799" EFFECT_SIZE="2.5" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="1.5" ORDER="18" SD_1="3.5" SD_2="1.5" SE="0.7615773105863908" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="98.88906119012535" CI_START="1.2899009444569678" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="11.294117647058824" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="1.9951482539074972" LOG_CI_START="0.11055636074305428" LOG_EFFECT_SIZE="1.0528523073252758" METHOD="MH" NO="7" P_CHI2="1.0" P_Q="0.0" P_Z="0.02853004969348865" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.00000000000001" Z="2.189919855733327">
<NAME>Number requiring transfusion</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="98.88906119012535" CI_START="1.2899009444569678" EFFECT_SIZE="11.294117647058824" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="1" LOG_CI_END="1.9951482539074972" LOG_CI_START="0.11055636074305428" LOG_EFFECT_SIZE="1.0528523073252758" ORDER="19" O_E="0.0" SE="1.107018606925119" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="1.2254901960784315" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="14.402653540895493" CI_START="-24.402653540895493" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.08" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.6135052680482206" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="99.99999999999999" Z="0.5050762722761054">
<NAME>Peak bilirubin (mumol/litre)</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="14.402653540895493" CI_START="-24.402653540895493" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="38.0" MEAN_2="43.0" ORDER="20" SD_1="35.0" SD_2="35.0" SE="9.899494936611665" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="12.087230594797424" CI_START="-10.087230594797424" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.09" NO="9" P_CHI2="1.0" P_Q="1.0" P_Z="0.8596837952762271" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="0.17677669529663687">
<NAME>Peak prothrombin activity (percentage of activity)</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="12.087230594797424" CI_START="-10.087230594797424" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="71.0" MEAN_2="70.0" ORDER="21" SD_1="20.0" SD_2="20.0" SE="5.656854249492381" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="18.65157792533578" CI_START="-60.65157792533575" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-20.999999999999986" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.10" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.29925943491529305" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="1.0380228437023185">
<NAME>Transection time (minutes)</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="18.65157792533578" CI_START="-60.65157792533575" EFFECT_SIZE="-20.999999999999986" ESTIMABLE="YES" MEAN_1="118.7" MEAN_2="139.7" ORDER="22" SD_1="78.9" SD_2="63.3" SE="20.230768645802858" STUDY_ID="STD-Koo-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.306675064432188" CI_START="0.8933249355678126" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.6" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.11" MODIFIED="2008-06-30 17:45:58 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="9.096680072868533E-6" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="4.437601569801833">
<NAME>Transection speed (sq cm/minute)</NAME>
<GROUP_LABEL_1>CUSA</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours CUSA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.306675064432188" CI_START="0.8933249355678126" EFFECT_SIZE="1.6" ESTIMABLE="YES" MEAN_1="-2.3" MEAN_2="-3.9" MODIFIED="2008-06-30 17:45:58 +0100" MODIFIED_BY="Kurinchi S Gurusamy" ORDER="23" SD_1="1.0" SD_2="1.5" SE="0.36055512754639896" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2008-09-27 17:14:05 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="3">
<NAME>Radio frequency dissecting sealer versus clamp-crush</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2008-06-30 07:55:56 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="89" TOTAL_2="91" WEIGHT="0.0" Z="0.0">
<NAME>Peri-operative mortality</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-Crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="24" O_E="0.0" SE="0.0" STUDY_ID="STD-Arita-2005" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="25" O_E="0.0" SE="0.0" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2008-06-30 07:55:56 +0100" MODIFIED_BY="Kurinchi S Gurusamy" ORDER="197" O_E="0.0" SE="0.0" STUDY_ID="STD-Lupo-2007" TOTAL_1="24" TOTAL_2="26" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3939293112169021" CI_END="3.9459254216358715" CI_START="0.1387876724749975" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.7400309486965837" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.5961488727869059" LOG_CI_START="-0.8576491074679511" LOG_EFFECT_SIZE="-0.13075011734052264" METHOD="MH" MODIFIED="2008-06-30 07:40:25 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="2" P_CHI2="0.5302415734923867" P_Q="0.0" P_Z="0.7244286320396447" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="49" TOTAL_2="51" WEIGHT="100.0" Z="0.3525462608180071">
<NAME>Liver failure</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.245465728677027" CI_START="0.012439247458696873" EFFECT_SIZE="0.3202614379084967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9162151909304669" LOG_CI_START="-1.9052058925086373" LOG_EFFECT_SIZE="-0.4944953507890852" ORDER="26" O_E="0.0" SE="1.6573167106717377" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.7466986794717885" WEIGHT="45.530294012617546"/>
<DICH_DATA CI_END="8.41966367175445" CI_START="0.14134562745308746" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.9252947437064848" LOG_CI_START="-0.8497176219276854" LOG_EFFECT_SIZE="0.037788560889399754" ORDER="193" O_E="0.0" SE="1.0426510500264277" STUDY_ID="STD-Lupo-2007" TOTAL_1="24" TOTAL_2="26" VAR="1.0871212121212122" WEIGHT="54.46970598738245"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Bleeding requiring percutaneous drainage</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="27" O_E="0.0" SE="0.0" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.271490484435559" CI_END="13.154941923189103" CI_START="0.21749516474169708" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.6914893617021278" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="1.1190889350903515" LOG_CI_START="-0.6625503936488458" LOG_EFFECT_SIZE="0.22826927072075284" METHOD="MH" NO="4" P_CHI2="0.6023337433837113" P_Q="0.0" P_Z="0.6155032262084099" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="65" WEIGHT="100.0" Z="0.5022335802460174">
<NAME>Bile leak requiring operation</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="16.56212933664009" CI_START="0.06037870974644056" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2191161718029548" LOG_CI_START="-1.2191161718029548" LOG_EFFECT_SIZE="0.0" ORDER="28" O_E="0.0" SE="1.4322297480788657" STUDY_ID="STD-Arita-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.051282051282051" WEIGHT="67.42021276595744"/>
<DICH_DATA CI_END="80.39071521974202" CI_START="0.1212787770764828" EFFECT_SIZE="3.122448979591837" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9052058925086373" LOG_CI_START="-0.9162151909304669" LOG_EFFECT_SIZE="0.49449535078908513" ORDER="29" O_E="0.0" SE="1.6573167106717377" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.7466986794717885" WEIGHT="32.57978723404255"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3336929928797212" CI_END="3.733177031062166" CI_START="0.1308620226962113" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.6989499963286585" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-003.05" LOG_CI_END="0.572078585101886" LOG_CI_START="-0.8831863712223256" LOG_EFFECT_SIZE="-0.1555538930602198" METHOD="MH" NO="5" P_CHI2="0.5634927285167153" P_Q="0.0" P_Z="0.6752141048820666" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="65" WEIGHT="100.0" Z="0.41900277571873745">
<NAME>Bile leak requiring percutaneous drainage</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.222425090696795" CI_START="0.01285410105249821" EFFECT_SIZE="0.32510288065843623" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9149999255909688" LOG_CI_START="-1.8909582902067104" LOG_EFFECT_SIZE="-0.48797918230787074" ORDER="30" O_E="0.0" SE="1.6482337456767353" STUDY_ID="STD-Arita-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.7166744803875607" WEIGHT="44.60679932447316"/>
<DICH_DATA CI_END="7.716830394329012" CI_START="0.12958688333164425" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8874389551396173" LOG_CI_START="-0.8874389551396173" LOG_EFFECT_SIZE="0.0" ORDER="31" O_E="0.0" SE="1.0425720702853738" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="1.0869565217391304" WEIGHT="55.393200675526835"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.5527031083062403" CI_END="4.2166915560879215" CI_START="0.23715275037279707" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-003.06" LOG_CI_END="0.6249718342640495" LOG_CI_START="-0.6249718342640495" LOG_EFFECT_SIZE="0.0" METHOD="MH" NO="6" P_CHI2="0.457215402776197" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="65" TOTAL_2="65" WEIGHT="100.0" Z="0.0">
<NAME>Bile leak requiring intervention</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.598801841139143" CI_START="0.0423919008857398" EFFECT_SIZE="0.48717948717948717" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7480950967461457" LOG_CI_START="-1.3727171088934864" LOG_EFFECT_SIZE="-0.31231100607367024" ORDER="32" O_E="0.0" SE="1.2457755877824503" STUDY_ID="STD-Arita-2005" TOTAL_1="40" TOTAL_2="40" VAR="1.5519568151147098" WEIGHT="52.56064690026954"/>
<DICH_DATA CI_END="10.300188314968311" CI_START="0.23875235477999107" EFFECT_SIZE="1.5681818181818181" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="1.0128451648414807" LOG_CI_START="-0.6220523363393449" LOG_EFFECT_SIZE="0.19539641425106788" ORDER="33" O_E="0.0" SE="0.9603468850667679" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="0.922266139657444" WEIGHT="47.439353099730454"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="176.32057860274617" CI_START="0.42218996437771206" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="8.627906976744185" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.07" LOG_CI_END="2.2463030023280406" LOG_CI_START="-0.3744920942571221" LOG_EFFECT_SIZE="0.9359054540354593" METHOD="MH" MODIFIED="2008-06-30 17:46:50 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="7" P_CHI2="1.0" P_Q="0.0" P_Z="0.16156259005007662" Q="0.0" RANDOM="NO" SCALE="209.19849188836758" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="24" TOTAL_2="26" WEIGHT="100.0" Z="1.3998354814034966">
<NAME>Biliary fistula</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="176.32057860274617" CI_START="0.42218996437771206" EFFECT_SIZE="8.627906976744185" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.2463030023280406" LOG_CI_START="-0.3744920942571221" LOG_EFFECT_SIZE="0.9359054540354593" ORDER="196" O_E="0.0" SE="1.539468012879081" STUDY_ID="STD-Lupo-2007" TOTAL_1="24" TOTAL_2="26" VAR="2.369961762677866" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3457813786708014" CI_END="88.27885368798319" CI_START="1.375618451577999" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="OR" EFFECT_SIZE="11.019892014776923" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.08" LOG_CI_END="1.945856685157768" LOG_CI_START="0.13849799250964723" LOG_EFFECT_SIZE="1.0421773388337077" METHOD="MH" MODIFIED="2008-06-30 07:42:13 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="8" P_CHI2="0.556511152058037" P_Q="0.0" P_Z="0.023799644186684007" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="64" TOTAL_2="66" WEIGHT="100.0" Z="2.260348272788094">
<NAME>Infected abdominal collections</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="113.10618837827289" CI_START="0.24459198914395391" EFFECT_SIZE="5.259740259740259" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.053486367127151" LOG_CI_START="-0.6115577710427776" LOG_EFFECT_SIZE="0.7209642980421866" ORDER="34" O_E="0.0" SE="1.5654601189422608" STUDY_ID="STD-Arita-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.4506653839987176" WEIGHT="56.89116226200625"/>
<DICH_DATA CI_END="351.2214352973982" CI_START="0.9873110151298743" EFFECT_SIZE="18.62162162162162" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.5455810133482384" LOG_CI_START="-0.005546017666976864" LOG_EFFECT_SIZE="1.270017497840631" ORDER="194" O_E="0.0" SE="1.4985446463008072" STUDY_ID="STD-Lupo-2007" TOTAL_1="24" TOTAL_2="26" VAR="2.2456360569568115" WEIGHT="43.10883773799375"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="68.46144087348007" CI_START="0.8390189058312254" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="7.578947368421052" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-003.09" LOG_CI_END="1.835446035275367" LOG_CI_START="-0.07622825299052571" LOG_EFFECT_SIZE="0.8796088911424207" METHOD="MH" MODIFIED="2008-06-30 07:42:12 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="9" P_CHI2="1.0" P_Q="0.0" P_Z="0.0712851943231524" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="99.99999999999999" Z="1.803656363118452">
<NAME>Wound infection</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="68.46144087348013" CI_START="0.839018905831225" EFFECT_SIZE="7.578947368421052" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.8354460352753674" LOG_CI_START="-0.07622825299052595" LOG_EFFECT_SIZE="0.8796088911424207" ORDER="35" O_E="0.0" SE="1.1229269398677288" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="1.2609649122807018" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.879981992270027" CI_START="0.9200180077299728" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.9" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.10" MODIFIED="2008-09-26 11:10:26 +0100" MODIFIED_BY="dimitrinka nikolova" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="1.4469608785436846E-4" Q="0.0" RANDOM="NO" SCALE="18.23406931874937" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="3.8">
<NAME>Transection blood loss (ml/sq cm)</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.879981992270027" CI_START="0.9200180077299728" EFFECT_SIZE="1.9" ESTIMABLE="YES" MEAN_1="3.4" MEAN_2="1.5" ORDER="36" SD_1="2.0" SD_2="1.5" SE="0.5" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.7069503957142156" CI_START="1.2730496042857844" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.49" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.11" MODIFIED="2008-09-27 17:11:53 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="2.6568116556531587E-41" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="40" TOTAL_2="40" UNITS="" WEIGHT="99.99999999999999" Z="13.460894262721665">
<NAME>Number of units transfused</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.7069503957142156" CI_START="1.2730496042857844" EFFECT_SIZE="1.49" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="0.01" MODIFIED="2008-09-27 17:11:53 +0100" MODIFIED_BY="Kurinchi S Gurusamy" ORDER="37" SD_1="0.7" SD_2="0.01" SE="0.11069101137852161" STUDY_ID="STD-Arita-2005" TOTAL_1="40" TOTAL_2="40" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="412.67257783703405" CI_START="307.30742216296596" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="359.99" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.12" MODIFIED="2008-09-27 17:14:05 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="12" P_CHI2="1.0" P_Q="1.0" P_Z="6.661748836052086E-41" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="40" TOTAL_2="40" UNITS="" WEIGHT="100.0" Z="13.392803916640998">
<NAME>Blood transfused (ml)</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="412.67257783703405" CI_START="307.30742216296596" EFFECT_SIZE="359.99" ESTIMABLE="YES" MEAN_1="360.0" MEAN_2="0.01" MODIFIED="2008-09-27 17:14:05 +0100" MODIFIED_BY="Kurinchi S Gurusamy" ORDER="38" SD_1="170.0" SD_2="0.01" SE="26.87936015793531" STUDY_ID="STD-Arita-2005" TOTAL_1="40" TOTAL_2="40" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="5.132308372009502" CI_END="2.817298662236257" CI_START="0.5042309159518382" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.191876287610957" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" I2="61.031180220822925" I2_Q="0.0" ID="CMP-003.13" LOG_CI_END="0.449832889046749" LOG_CI_START="-0.29737052990974394" LOG_EFFECT_SIZE="0.07623117956850257" METHOD="MH" MODIFIED="2008-06-30 07:42:10 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="13" P_CHI2="0.07683054984164694" P_Q="0.0" P_Z="0.6892162880946315" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="89" TOTAL_2="91" WEIGHT="100.0" Z="0.3999188511795884">
<NAME>Number requiring transfusion</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="113.10618837827289" CI_START="0.24459198914395391" EFFECT_SIZE="5.259740259740259" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.053486367127151" LOG_CI_START="-0.6115577710427776" LOG_EFFECT_SIZE="0.7209642980421866" ORDER="39" O_E="0.0" SE="1.5654601189422608" STUDY_ID="STD-Arita-2005" TOTAL_1="40" TOTAL_2="40" VAR="2.4506653839987176" WEIGHT="4.896100923264745"/>
<DICH_DATA CI_END="55.66147268228821" CI_START="0.6467669334853117" EFFECT_SIZE="6.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.7455546926435572" LOG_CI_START="-0.18925219187627002" LOG_EFFECT_SIZE="0.7781512503836436" ORDER="40" O_E="0.0" SE="1.136515141415488" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="1.2916666666666667" WEIGHT="8.342447287432917"/>
<DICH_DATA CI_END="1.5713868540287432" CI_START="0.1590951326588017" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="13" LOG_CI_END="0.1962831155858535" LOG_CI_START="-0.7983431069138159" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="195" O_E="0.0" SE="0.584248366575512" STUDY_ID="STD-Lupo-2007" TOTAL_1="24" TOTAL_2="26" VAR="0.34134615384615385" WEIGHT="86.76145178930234"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="19.402653540895493" CI_START="-19.402653540895493" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.14" MODIFIED="2008-06-30 17:48:07 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="14" P_CHI2="1.0" P_Q="1.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="99.99999999999999" Z="0.0">
<NAME>Peak bilirubin (mumol/litre)</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="19.402653540895493" CI_START="-19.402653540895493" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="43.0" MEAN_2="43.0" ORDER="42" SD_1="35.0" SD_2="35.0" SE="9.899494936611665" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="27.65839233390516" CI_START="-25.65839233390516" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.15" MODIFIED="2008-06-30 17:48:15 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="15" P_CHI2="1.0" P_Q="1.0" P_Z="0.9413911659175257" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="0.07352146220938077">
<NAME>Peak prothrombin activity (percentage of activity)</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="27.65839233390516" CI_START="-25.65839233390516" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="71.0" MEAN_2="70.0" ORDER="43" SD_1="65.0" SD_2="20.0" SE="13.601470508735444" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.231542294609807" CI_START="0.5684577053901931" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.4" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.16" MODIFIED="2008-06-30 18:02:57 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="16" P_CHI2="1.0" P_Q="1.0" P_Z="9.674284502755175E-4" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="3.2998316455372216">
<NAME>Transection speed (sq cm/minute)</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.231542294609807" CI_START="0.5684577053901931" EFFECT_SIZE="1.4" ESTIMABLE="YES" MEAN_1="-2.5" MEAN_2="-3.9" MODIFIED="2008-06-30 18:02:39 +0100" MODIFIED_BY="Kurinchi S Gurusamy" ORDER="41" SD_1="1.5" SD_2="1.5" SE="0.4242640687119285" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2008-06-30 18:01:13 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="4">
<NAME>Hydrojet versus clamp-crush</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="118.95804526560195" CI_START="0.24745191881562512" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="5.425531914893617" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="2.075393819187927" LOG_CI_START="-0.6065091741914517" LOG_EFFECT_SIZE="0.7344423224982377" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.28305719878385516" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="1.0734769336340946">
<NAME>Peri-operative mortality</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="118.95804526560195" CI_START="0.24745191881562512" EFFECT_SIZE="5.425531914893617" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.075393819187927" LOG_CI_START="-0.6065091741914517" LOG_EFFECT_SIZE="0.7344423224982377" ORDER="44" O_E="0.0" SE="1.575363093944971" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.4817688777638716" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="16.927920091810748" CI_START="0.059074002864874804" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="1.2286036002743048" LOG_CI_START="-1.2286036002743048" LOG_EFFECT_SIZE="0.0" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.0">
<NAME>Liver failure</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="16.927920091810748" CI_START="0.059074002864874804" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2286036002743048" LOG_CI_START="-1.2286036002743048" LOG_EFFECT_SIZE="0.0" ORDER="45" O_E="0.0" SE="1.4433756729740645" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.0833333333333335" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="80.39071521974202" CI_START="0.1212787770764828" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="3.122448979591837" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="1.9052058925086373" LOG_CI_START="-0.9162151909304669" LOG_EFFECT_SIZE="0.49449535078908513" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.49206712738309877" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.6870247647598439">
<NAME>Bleeding requiring percutaneous drainage</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="80.39071521974202" CI_START="0.1212787770764828" EFFECT_SIZE="3.122448979591837" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9052058925086373" LOG_CI_START="-0.9162151909304669" LOG_EFFECT_SIZE="0.49449535078908513" ORDER="46" O_E="0.0" SE="1.6573167106717377" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.7466986794717885" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.04118911175263" CI_START="0.008406325085178254" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.1843137254901961" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="0.6065091741914517" LOG_CI_START="-2.075393819187927" LOG_EFFECT_SIZE="-0.7344423224982377" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.28305719878385516" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="1.0734769336340946">
<NAME>Bile leak requiring percutaneous drainage</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.041189111752629" CI_START="0.008406325085178254" EFFECT_SIZE="0.1843137254901961" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6065091741914516" LOG_CI_START="-2.075393819187927" LOG_EFFECT_SIZE="-0.7344423224982377" ORDER="47" O_E="0.0" SE="1.5753630939449708" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.481768877763871" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.245465728677031" CI_START="0.012439247458696873" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.3202614379084967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="0.9162151909304671" LOG_CI_START="-1.9052058925086373" LOG_EFFECT_SIZE="-0.4944953507890852" METHOD="MH" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.4920671273830989" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.6870247647598438">
<NAME>Wound infection</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.245465728677027" CI_START="0.012439247458696873" EFFECT_SIZE="0.3202614379084967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9162151909304669" LOG_CI_START="-1.9052058925086373" LOG_EFFECT_SIZE="-0.4944953507890852" ORDER="48" O_E="0.0" SE="1.6573167106717377" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.7466986794717885" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="3.1428455709482375" CI_START="0.8571544290517628" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="6.036441981547936E-4" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="3.4299717028501773">
<NAME>Transection blood loss (ml/sq cm)</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.1428455709482375" CI_START="0.8571544290517628" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="3.5" MEAN_2="1.5" ORDER="49" SD_1="2.5" SD_2="1.5" SE="0.58309518948453" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="98.88906119012535" CI_START="1.2899009444569678" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="11.294117647058824" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-004.07" LOG_CI_END="1.9951482539074972" LOG_CI_START="0.11055636074305428" LOG_EFFECT_SIZE="1.0528523073252758" METHOD="MH" MODIFIED="2008-06-30 17:49:18 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="7" P_CHI2="1.0" P_Q="0.0" P_Z="0.02853004969348865" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.00000000000001" Z="2.189919855733327">
<NAME>Number requiring transfusion</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="98.88906119012535" CI_START="1.2899009444569678" EFFECT_SIZE="11.294117647058824" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="1" LOG_CI_END="1.9951482539074972" LOG_CI_START="0.11055636074305428" LOG_EFFECT_SIZE="1.0528523073252758" ORDER="50" O_E="0.0" SE="1.107018606925119" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="1.2254901960784315" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="33.83470294336918" CI_START="-7.834702943369177" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="13.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.08" MODIFIED="2008-06-30 17:49:18 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.22135346653529853" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="1.2229371288986763">
<NAME>Peak bilirubin (mumol/litre)</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="33.83470294336918" CI_START="-7.834702943369177" EFFECT_SIZE="13.0" ESTIMABLE="YES" MEAN_1="56.0" MEAN_2="43.0" ORDER="52" SD_1="40.0" SD_2="35.0" SE="10.63014581273465" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="9.087230594797424" CI_START="-13.087230594797424" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.09" MODIFIED="2008-06-30 17:49:23 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="9" P_CHI2="1.0" P_Q="1.0" P_Z="0.7236736105056623" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="0.35355339059327373">
<NAME>Peak prothrombin activity (percentage of activity)</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="9.087230594797424" CI_START="-13.087230594797424" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="68.0" MEAN_2="70.0" ORDER="53" SD_1="20.0" SD_2="20.0" SE="5.656854249492381" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.7391003653507353E-31" CI_END="2.3315422946098066" CI_START="0.668457705390193" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.4999999999999998" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-004.10" MODIFIED="2008-06-30 18:01:13 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="10" P_CHI2="0.0" P_Q="1.0" P_Z="4.0695201746003795E-4" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="3.5355339059327373">
<NAME>Transection speed (sq cm/minute)</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.3315422946098066" CI_START="0.6684577053901932" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="-2.4" MEAN_2="-3.9" MODIFIED="2008-06-30 18:00:49 +0100" MODIFIED_BY="Kurinchi S Gurusamy" ORDER="51" SD_1="1.5" SD_2="1.5" SE="0.4242640687119285" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>Sharp dissection versus clamp-crush</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="41" TOTAL_2="41" WEIGHT="0.0" Z="0.0">
<NAME>Peri-operative mortality</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="54" O_E="0.0" SE="0.0" STUDY_ID="STD-Smyrniotis-2005" TOTAL_1="41" TOTAL_2="41" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="112.87623183851997" CI_START="0.24447784456518987" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="5.253164556962025" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="2.0526025028808323" LOG_CI_START="-0.6117604920375301" LOG_EFFECT_SIZE="0.7204210054216512" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.28918326184938636" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="41" TOTAL_2="41" WEIGHT="100.0" Z="1.059915054386826">
<NAME>Bleeding requiring re-operation</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="112.87623183851997" CI_START="0.24447784456518987" EFFECT_SIZE="5.253164556962025" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0526025028808323" LOG_CI_START="-0.6117604920375301" LOG_EFFECT_SIZE="0.7204210054216512" ORDER="55" O_E="0.0" SE="1.5650600120245777" STUDY_ID="STD-Smyrniotis-2005" TOTAL_1="41" TOTAL_2="41" VAR="2.449412841238371" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="23.54950958749754" CI_START="0.17867709891274353" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="2.051282051282051" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="1.3719818674877888" LOG_CI_START="-0.7479311075569" LOG_EFFECT_SIZE="0.3120253799654443" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.5639626482899769" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="41" TOTAL_2="41" WEIGHT="100.0" Z="0.5769656718873611">
<NAME>Bile leak requiring intervention</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="23.54950958749754" CI_START="0.17867709891274353" EFFECT_SIZE="2.051282051282051" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3719818674877888" LOG_CI_START="-0.7479311075569" LOG_EFFECT_SIZE="0.3120253799654443" ORDER="56" O_E="0.0" SE="1.2452473752797175" STUDY_ID="STD-Smyrniotis-2005" TOTAL_1="41" TOTAL_2="41" VAR="1.5506410256410255" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="16.54760473111572" CI_START="0.06043170695995802" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-005.04" LOG_CI_END="1.2187351384535003" LOG_CI_START="-1.2187351384535003" LOG_EFFECT_SIZE="0.0" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="41" TOTAL_2="41" WEIGHT="100.0" Z="0.0">
<NAME>Abdominal collections requiring drainage</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="16.54760473111571" CI_START="0.060431706959958045" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2187351384535001" LOG_CI_START="-1.2187351384535001" LOG_EFFECT_SIZE="0.0" ORDER="57" O_E="0.0" SE="1.4317821063276353" STUDY_ID="STD-Smyrniotis-2005" TOTAL_1="41" TOTAL_2="41" VAR="2.05" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="16.54760473111572" CI_START="0.06043170695995802" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-005.05" LOG_CI_END="1.2187351384535003" LOG_CI_START="-1.2187351384535003" LOG_EFFECT_SIZE="0.0" METHOD="MH" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="41" TOTAL_2="41" WEIGHT="100.0" Z="0.0">
<NAME>Wound infection</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="16.54760473111571" CI_START="0.060431706959958045" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2187351384535001" LOG_CI_START="-1.2187351384535001" LOG_EFFECT_SIZE="0.0" ORDER="58" O_E="0.0" SE="1.4317821063276353" STUDY_ID="STD-Smyrniotis-2005" TOTAL_1="41" TOTAL_2="41" VAR="2.05" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.0085546880349847" CI_START="0.32244166773950866" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8047619047619048" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-005.06" LOG_CI_END="0.3028836610059427" LOG_CI_START="-0.49154884124643416" LOG_EFFECT_SIZE="-0.09433259012024571" METHOD="MH" NO="6" P_CHI2="1.0" P_Q="0.0" P_Z="0.6416017111178269" Q="0.0" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="41" TOTAL_2="41" WEIGHT="99.99999999999999" Z="0.4654605109430047">
<NAME>Number requiring transfusion</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Clamp-crush</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours clamp-crush</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.0085546880349847" CI_START="0.32244166773950866" EFFECT_SIZE="0.8047619047619048" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.3028836610059427" LOG_CI_START="-0.49154884124643416" LOG_EFFECT_SIZE="-0.09433259012024571" ORDER="59" O_E="0.0" SE="0.46665358432735493" STUDY_ID="STD-Smyrniotis-2005" TOTAL_1="41" TOTAL_2="41" VAR="0.21776556776556777" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2008-06-30 18:06:50 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="6">
<NAME>Hydrojet versus CUSA</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="7.716830394329012" CI_START="0.12958688333164425" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="0.8874389551396173" LOG_CI_START="-0.8874389551396173" LOG_EFFECT_SIZE="0.0" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.0">
<NAME>Peri-operative mortality</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.716830394329012" CI_START="0.12958688333164425" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8874389551396173" LOG_CI_START="-0.8874389551396173" LOG_EFFECT_SIZE="0.0" ORDER="60" O_E="0.0" SE="1.0425720702853738" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="1.0869565217391304" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="16.927920091810748" CI_START="0.059074002864874804" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="1.2286036002743048" LOG_CI_START="-1.2286036002743048" LOG_EFFECT_SIZE="0.0" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.0">
<NAME>Liver failure</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<DICH_DATA CI_END="16.927920091810748" CI_START="0.059074002864874804" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2286036002743048" LOG_CI_START="-1.2286036002743048" LOG_EFFECT_SIZE="0.0" ORDER="61" O_E="0.0" SE="1.4433756729740645" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.0833333333333335" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="80.39071521974202" CI_START="0.1212787770764828" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="3.122448979591837" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.03" LOG_CI_END="1.9052058925086373" LOG_CI_START="-0.9162151909304669" LOG_EFFECT_SIZE="0.49449535078908513" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.49206712738309877" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.6870247647598439">
<NAME>Bleeding requiring percutaneous drainage</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<DICH_DATA CI_END="80.39071521974202" CI_START="0.1212787770764828" EFFECT_SIZE="3.122448979591837" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9052058925086373" LOG_CI_START="-0.9162151909304669" LOG_EFFECT_SIZE="0.49449535078908513" ORDER="62" O_E="0.0" SE="1.6573167106717377" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.7466986794717885" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.245465728677031" CI_START="0.012439247458696873" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.3202614379084967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-006.04" LOG_CI_END="0.9162151909304671" LOG_CI_START="-1.9052058925086373" LOG_EFFECT_SIZE="-0.4944953507890852" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.4920671273830989" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.6870247647598438">
<NAME>Bile leak requiring percutaneous drainage</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.245465728677027" CI_START="0.012439247458696873" EFFECT_SIZE="0.3202614379084967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9162151909304669" LOG_CI_START="-1.9052058925086373" LOG_EFFECT_SIZE="-0.4944953507890852" ORDER="63" O_E="0.0" SE="1.6573167106717377" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.7466986794717885" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Wound infection</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="64" O_E="0.0" SE="0.0" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2458.0286874406797" CI_START="-3094.0286874406797" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-318.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.06" MODIFIED="2008-06-30 18:06:50 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.8223542238462922" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="31" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="0.22451804979665063">
<NAME>Operative blood loss (ml)</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<CONT_DATA CI_END="2458.0286874406797" CI_START="-3094.0286874406797" EFFECT_SIZE="-318.0" ESTIMABLE="YES" MEAN_1="1479.0" MEAN_2="1797.0" ORDER="65" SD_1="5590.0" SD_2="5472.0" SE="1416.3671931411188" STUDY_ID="STD-Rau-2001" TOTAL_1="31" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.1860247706702454" CI_START="-2.1860247706702456" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.07" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.5610799324718774" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="0.5812381937190965">
<NAME>Transection blood loss (ml/sq cm)</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.1860247706702454" CI_START="-2.1860247706702456" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="3.5" MEAN_2="4.0" ORDER="66" SD_1="2.5" SD_2="3.5" SE="0.8602325267042626" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.4051579338895832" CI_START="-0.599400011674174" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.09712103889229542" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.08" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.7047026377676859" Q="0.0" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="31" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="0.37898010604691706">
<NAME>Mean blood transfusion requirements</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.4051579338895832" CI_START="-0.599400011674174" EFFECT_SIZE="-0.09712103889229542" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="2.5" ORDER="67" SD_1="9.4" SD_2="10.9" SE="0.2562694910436064" STUDY_ID="STD-Rau-2001" TOTAL_1="31" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.2818350259814206" CI_START="0.30470757734111076" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-006.09" LOG_CI_END="0.5161167457887657" LOG_CI_START="-0.5161167457887657" LOG_EFFECT_SIZE="0.0" METHOD="MH" NO="9" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.00000000000001" Z="0.0">
<NAME>Number requiring transfusion</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.2818350259814215" CI_START="0.3047075773411107" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.5161167457887657" LOG_CI_START="-0.5161167457887657" LOG_EFFECT_SIZE="0.0" ORDER="68" O_E="0.0" SE="0.6063390625908325" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="0.36764705882352944" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="38.83470294336918" CI_START="-2.8347029433691766" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="18.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.10" MODIFIED="2008-06-30 17:54:00 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.09039884175661603" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="1.693297563090475">
<NAME>Peak bilirubin (mumol/litre)</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<CONT_DATA CI_END="38.83470294336918" CI_START="-2.8347029433691766" EFFECT_SIZE="18.0" ESTIMABLE="YES" MEAN_1="56.0" MEAN_2="38.0" ORDER="72" SD_1="40.0" SD_2="35.0" SE="10.63014581273465" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="8.087230594797424" CI_START="-14.087230594797424" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.11" MODIFIED="2008-06-30 17:54:06 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.5958830927779415" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="0.5303300858899106">
<NAME>Peak prothrombin activity (percentage of activity)</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<CONT_DATA CI_END="8.087230594797424" CI_START="-14.087230594797424" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="68.0" MEAN_2="71.0" ORDER="73" SD_1="20.0" SD_2="20.0" SE="5.656854249492381" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="25.03215284528153" CI_START="-61.03215284528153" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-18.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.12" MODIFIED="2008-06-30 17:54:06 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="12" P_CHI2="1.0" P_Q="1.0" P_Z="0.41230903462386204" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="31" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="0.8198370146286872">
<NAME>Transection time (minutes)</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<CONT_DATA CI_END="25.03215284528153" CI_START="-61.03215284528153" EFFECT_SIZE="-18.0" ESTIMABLE="YES" MEAN_1="28.0" MEAN_2="46.0" ORDER="69" SD_1="61.2" SD_2="104.1" SE="21.95558346210117" STUDY_ID="STD-Rau-2001" TOTAL_1="31" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.10358376675927397" CI_END="0.362486732307069" CI_START="-0.3818868427039445" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="-0.009700055198437751" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.13" MODIFIED="2008-06-30 18:00:22 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="13" P_CHI2="0.7475706661390426" P_Q="1.0" P_Z="0.9592607928777113" Q="0.0" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="55" UNITS="" WEIGHT="100.0" Z="0.05108122984270964">
<NAME>Transection speed (sq cm/minute)</NAME>
<GROUP_LABEL_1>Hydrojet</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hydrojet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.47737141447811215" CI_START="-0.6318000360738342" EFFECT_SIZE="-0.07721431079786101" ESTIMABLE="YES" MEAN_1="-2.4" MEAN_2="-2.3" MODIFIED="2008-06-30 17:59:54 +0100" MODIFIED_BY="Kurinchi S Gurusamy" ORDER="70" SD_1="1.5" SD_2="1.0" SE="0.28295710005412067" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="45.038563445692944"/>
<CONT_DATA CI_END="0.5476576041533555" CI_START="-0.45640758329688164" EFFECT_SIZE="0.04562501042823692" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="15.1" MODIFIED="2008-06-30 17:59:59 +0100" MODIFIED_BY="Kurinchi S Gurusamy" ORDER="71" SD_1="119.2" SD_2="90.4" SE="0.25614378513334307" STUDY_ID="STD-Rau-2001" TOTAL_1="31" TOTAL_2="30" WEIGHT="54.96143655430706"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2008-09-26 11:16:09 +0100" MODIFIED_BY="dimitrinka nikolova" NO="7">
<NAME>Radio frequency dissecting sealer versus CUSA</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.04118911175263" CI_START="0.008406325085178254" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.1843137254901961" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="0.6065091741914517" LOG_CI_START="-2.075393819187927" LOG_EFFECT_SIZE="-0.7344423224982377" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.28305719878385516" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="1.0734769336340946">
<NAME>Peri-operative mortality</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.041189111752629" CI_START="0.008406325085178254" EFFECT_SIZE="0.1843137254901961" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6065091741914516" LOG_CI_START="-2.075393819187927" LOG_EFFECT_SIZE="-0.7344423224982377" ORDER="74" O_E="0.0" SE="1.5753630939449708" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.481768877763871" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.245465728677031" CI_START="0.012439247458696873" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.3202614379084967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-007.02" LOG_CI_END="0.9162151909304671" LOG_CI_START="-1.9052058925086373" LOG_EFFECT_SIZE="-0.4944953507890852" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.4920671273830989" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.6870247647598438">
<NAME>Liver failure</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.245465728677027" CI_START="0.012439247458696873" EFFECT_SIZE="0.3202614379084967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9162151909304669" LOG_CI_START="-1.9052058925086373" LOG_EFFECT_SIZE="-0.4944953507890852" ORDER="75" O_E="0.0" SE="1.6573167106717377" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.7466986794717885" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-007.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Bleeding requiring percutaneous drainage</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="76" O_E="0.0" SE="0.0" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="80.39071521974202" CI_START="0.1212787770764828" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="3.122448979591837" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-007.04" LOG_CI_END="1.9052058925086373" LOG_CI_START="-0.9162151909304669" LOG_EFFECT_SIZE="0.49449535078908513" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.49206712738309877" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.6870247647598439">
<NAME>Bile leak requiring operation</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<DICH_DATA CI_END="80.39071521974202" CI_START="0.1212787770764828" EFFECT_SIZE="3.122448979591837" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9052058925086373" LOG_CI_START="-0.9162151909304669" LOG_EFFECT_SIZE="0.49449535078908513" ORDER="77" O_E="0.0" SE="1.6573167106717377" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.7466986794717885" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="24.614881794088667" CI_START="0.1769412325463796" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="2.0869565217391304" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-007.05" LOG_CI_END="1.3911977545390697" LOG_CI_START="-0.752170951823081" LOG_EFFECT_SIZE="0.31951340135799433" METHOD="MH" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.5589873678720993" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.5843462745170354">
<NAME>Bile leak requiring percutaneous drainage</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<DICH_DATA CI_END="24.614881794088667" CI_START="0.1769412325463796" EFFECT_SIZE="2.0869565217391304" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3911977545390697" LOG_CI_START="-0.752170951823081" LOG_EFFECT_SIZE="0.31951340135799433" ORDER="78" O_E="0.0" SE="1.2590253879633373" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="1.585144927536232" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="320.3652461936804" CI_START="0.902095353455668" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="17.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-007.06" LOG_CI_END="2.5056453969098307" LOG_CI_START="-0.04474755415328238" LOG_EFFECT_SIZE="1.2304489213782739" METHOD="MH" NO="6" P_CHI2="1.0" P_Q="0.0" P_Z="0.05859932605279095" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="1.8911874499279033">
<NAME>Wound infection</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<DICH_DATA CI_END="320.3652461936804" CI_START="0.902095353455668" EFFECT_SIZE="17.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.5056453969098307" LOG_CI_START="-0.04474755415328238" LOG_EFFECT_SIZE="1.2304489213782739" ORDER="79" O_E="0.0" SE="1.4981134441031878" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.244343891402715" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.9801734820744152" CI_START="-2.1801734820744154" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.6000000000000001" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.07" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.456750408299462" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="99.99999999999999" Z="0.7442084075352507">
<NAME>Transection blood loss (ml/sqcm)</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.9801734820744152" CI_START="-2.1801734820744154" EFFECT_SIZE="-0.6000000000000001" ESTIMABLE="YES" MEAN_1="3.4" MEAN_2="4.0" ORDER="80" SD_1="2.0" SD_2="3.5" SE="0.806225774829855" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.931724708174474" CI_START="0.1461008192863624" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.53125" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-007.08" LOG_CI_END="0.2859452347919624" LOG_CI_START="-0.8353473486752265" LOG_EFFECT_SIZE="-0.27470105694163205" METHOD="MH" NO="8" P_CHI2="1.0" P_Q="0.0" P_Z="0.33689031236768663" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.9603277254467637">
<NAME>Number requiring transfusion</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9317247081744744" CI_START="0.1461008192863624" EFFECT_SIZE="0.53125" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.28594523479196243" LOG_CI_START="-0.8353473486752265" LOG_EFFECT_SIZE="-0.27470105694163205" ORDER="81" O_E="0.0" SE="0.6586528140164322" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="0.4338235294117647" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="24.402653540895493" CI_START="-14.402653540895493" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="5.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.09" MODIFIED="2008-06-30 17:54:17 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="9" P_CHI2="1.0" P_Q="1.0" P_Z="0.6135052680482206" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="99.99999999999999" Z="0.5050762722761054">
<NAME>Peak bilirubin (mumol/litre)</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<CONT_DATA CI_END="24.402653540895493" CI_START="-14.402653540895493" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="43.0" MEAN_2="38.0" ORDER="83" SD_1="35.0" SD_2="35.0" SE="9.899494936611665" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="26.65839233390516" CI_START="-26.65839233390516" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.10" MODIFIED="2008-06-30 17:54:23 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="0.0">
<NAME>Peak prothrombin activity (percentage of activity)</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<CONT_DATA CI_END="26.65839233390516" CI_START="-26.65839233390516" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="71.0" MEAN_2="71.0" ORDER="84" SD_1="65.0" SD_2="20.0" SE="13.601470508735444" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.5066750644321873" CI_START="-0.9066750644321877" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.11" MODIFIED="2008-06-30 17:59:38 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.5790997444747108" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="0.5547001962252296">
<NAME>Transection speed (sq cm/minute)</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>CUSA</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CUSA</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5066750644321873" CI_START="-0.9066750644321877" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" MEAN_1="-2.5" MEAN_2="-2.3" MODIFIED="2008-06-30 17:57:55 +0100" MODIFIED_BY="Kurinchi S Gurusamy" ORDER="82" SD_1="1.5" SD_2="1.0" SE="0.36055512754639896" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2008-09-26 11:16:21 +0100" MODIFIED_BY="dimitrinka nikolova" NO="8">
<NAME>Radio frequency dissecting sealer versus hydrojet</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.04118911175263" CI_START="0.008406325085178254" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.1843137254901961" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-008.01" LOG_CI_END="0.6065091741914517" LOG_CI_START="-2.075393819187927" LOG_EFFECT_SIZE="-0.7344423224982377" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.28305719878385516" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="1.0734769336340946">
<NAME>Peri-operative mortality</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrojet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours hydrojet</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.041189111752629" CI_START="0.008406325085178254" EFFECT_SIZE="0.1843137254901961" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6065091741914516" LOG_CI_START="-2.075393819187927" LOG_EFFECT_SIZE="-0.7344423224982377" ORDER="85" O_E="0.0" SE="1.5753630939449708" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.481768877763871" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.245465728677031" CI_START="0.012439247458696873" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.3202614379084967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-008.02" LOG_CI_END="0.9162151909304671" LOG_CI_START="-1.9052058925086373" LOG_EFFECT_SIZE="-0.4944953507890852" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.4920671273830989" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.6870247647598438">
<NAME>Liver failure</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrojet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours hydrojet</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.245465728677027" CI_START="0.012439247458696873" EFFECT_SIZE="0.3202614379084967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9162151909304669" LOG_CI_START="-1.9052058925086373" LOG_EFFECT_SIZE="-0.4944953507890852" ORDER="86" O_E="0.0" SE="1.6573167106717377" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.7466986794717885" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.245465728677031" CI_START="0.012439247458696873" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.3202614379084967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-008.03" LOG_CI_END="0.9162151909304671" LOG_CI_START="-1.9052058925086373" LOG_EFFECT_SIZE="-0.4944953507890852" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.4920671273830989" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.6870247647598438">
<NAME>Bleeding requiring percutaneous drainage</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrojet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours hydrojet</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.245465728677027" CI_START="0.012439247458696873" EFFECT_SIZE="0.3202614379084967" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9162151909304669" LOG_CI_START="-1.9052058925086373" LOG_EFFECT_SIZE="-0.4944953507890852" ORDER="87" O_E="0.0" SE="1.6573167106717377" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.7466986794717885" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="162.06560807328987" CI_START="0.38834752496850433" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="7.933333333333334" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-008.04" LOG_CI_END="2.209690863036748" LOG_CI_START="-0.41077945836304885" LOG_EFFECT_SIZE="0.8994557023368495" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.17846890176527952" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="1.345484257442536">
<NAME>Bile leak requiring intervention</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrojet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours hydrojet</GRAPH_LABEL_2>
<DICH_DATA CI_END="162.06560807328987" CI_START="0.38834752496850433" EFFECT_SIZE="7.933333333333334" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.209690863036748" LOG_CI_START="-0.41077945836304885" LOG_EFFECT_SIZE="0.8994557023368495" ORDER="88" O_E="0.0" SE="1.539277238327534" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.36937441643324" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="320.3652461936804" CI_START="0.902095353455668" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="17.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-008.05" LOG_CI_END="2.5056453969098307" LOG_CI_START="-0.04474755415328238" LOG_EFFECT_SIZE="1.2304489213782739" METHOD="MH" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.05859932605279095" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="1.8911874499279033">
<NAME>Wound infection</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrojet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours hydrojet</GRAPH_LABEL_2>
<DICH_DATA CI_END="320.3652461936804" CI_START="0.902095353455668" EFFECT_SIZE="17.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.5056453969098307" LOG_CI_START="-0.04474755415328238" LOG_EFFECT_SIZE="1.2304489213782739" ORDER="89" O_E="0.0" SE="1.4981134441031878" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="2.244343891402715" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.4801734820744152" CI_START="-1.6801734820744154" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.10000000000000009" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.06" MODIFIED="2008-09-26 11:07:17 +0100" MODIFIED_BY="dimitrinka nikolova" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.9012877732018131" Q="0.0" RANDOM="NO" SCALE="16.540539784330416" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="99.99999999999999" Z="0.12403473458920855">
<NAME>Transection blood loss (ml/sqcm)</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrojet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours hydrojet</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.4801734820744152" CI_START="-1.6801734820744154" EFFECT_SIZE="-0.10000000000000009" ESTIMABLE="YES" MEAN_1="3.4" MEAN_2="3.5" ORDER="90" SD_1="2.0" SD_2="3.5" SE="0.806225774829855" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.931724708174474" CI_START="0.1461008192863624" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.53125" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-008.07" LOG_CI_END="0.2859452347919624" LOG_CI_START="-0.8353473486752265" LOG_EFFECT_SIZE="-0.27470105694163205" METHOD="MH" NO="7" P_CHI2="1.0" P_Q="0.0" P_Z="0.33689031236768663" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0" Z="0.9603277254467637">
<NAME>Number requiring transfusion</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrojet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours hydrojet</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9317247081744744" CI_START="0.1461008192863624" EFFECT_SIZE="0.53125" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.28594523479196243" LOG_CI_START="-0.8353473486752265" LOG_EFFECT_SIZE="-0.27470105694163205" ORDER="91" O_E="0.0" SE="0.6586528140164322" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" VAR="0.4338235294117647" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="29.65839233390516" CI_START="-23.65839233390516" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.08" MODIFIED="2008-06-30 17:54:41 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.8254316336243109" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="0.22056438662814232">
<NAME>Peak prothrombin activity (percentage of activity)</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrojet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours hydrojet</GRAPH_LABEL_2>
<CONT_DATA CI_END="29.65839233390516" CI_START="-23.65839233390516" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="71.0" MEAN_2="68.0" ORDER="94" SD_1="65.0" SD_2="20.0" SE="13.601470508735444" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="7.834702943369177" CI_START="-33.83470294336918" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-13.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.09" MODIFIED="2008-06-30 17:54:41 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="9" P_CHI2="1.0" P_Q="1.0" P_Z="0.22135346653529853" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="1.2229371288986763">
<NAME>Peak bilirubin (mumol/litre)</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrojet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours hydrojet</GRAPH_LABEL_2>
<CONT_DATA CI_END="7.834702943369177" CI_START="-33.83470294336918" EFFECT_SIZE="-13.0" ESTIMABLE="YES" MEAN_1="43.0" MEAN_2="56.0" ORDER="93" SD_1="35.0" SD_2="40.0" SE="10.63014581273465" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.7315422946098067" CI_START="-0.9315422946098069" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.10000000000000009" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.10" MODIFIED="2008-06-30 17:59:13 +0100" MODIFIED_BY="Kurinchi S Gurusamy" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.813663715962916" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="0.23570226039551606">
<NAME>Transection speed (sq cm/minute)</NAME>
<GROUP_LABEL_1>RF dissecting sealer</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrojet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RFDS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours hydrojet</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.7315422946098067" CI_START="-0.9315422946098069" EFFECT_SIZE="-0.10000000000000009" ESTIMABLE="YES" MEAN_1="-2.5" MEAN_2="-2.4" MODIFIED="2008-06-30 17:58:14 +0100" MODIFIED_BY="Kurinchi S Gurusamy" ORDER="92" SD_1="1.5" SD_2="1.5" SE="0.4242640687119285" STUDY_ID="STD-Lesurtel-2005" TOTAL_1="25" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova">
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAYAAAAG8CAIAAABYHeU+AAAb70lEQVR42u3dv44USbbH8ZLGGQMD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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2008-10-27 16:38:37 +0100" MODIFIED_BY="dimitrinka nikolova" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAfMAAAEyCAMAAADZZcloAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-11-12 11:26:37 +0100" MODIFIED_BY="dimitrinka nikolova">
<APPENDIX ID="APP-01" MODIFIED="2008-11-12 11:26:37 +0100" MODIFIED_BY="dimitrinka nikolova" NO="1">
<TITLE MODIFIED="2008-04-14 15:07:59 +0100" MODIFIED_BY="Kate Whitfield">Search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-12 11:26:37 +0100" MODIFIED_BY="dimitrinka nikolova">
<TABLE COLS="3" ROWS="6">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Database</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Period of Search</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Search Strategy</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cochrane Hepato-Biliary Group Controlled Trials Register</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>March 2008</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(((liver OR hepatic) AND (segmentectomy OR resection OR transection)) OR hepatectomy) AND ( "blood loss" OR "blood losses" OR hemorrhage OR hemorrhages OR haemorrhage OR haemorrhages OR hemostasis OR hemostases OR haemostasis OR haemostases)<BR/>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cochrane Central Register of Controlled Trials in The Cochrane Library (CENTRAL)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Issue 1, 2008</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 liver OR hepatic<BR/>#2 MeSH descriptor Liver explode all trees<BR/>#3 (#1 OR #2)<BR/>#4 segmentectomy OR resection OR transection<BR/>#5 (#3 AND #4)<BR/>#6 MeSH descriptor Hepatectomy explode all trees<BR/>#7 (#5 OR #6)<BR/>#8 MeSH descriptor Hemorrhage explode all trees<BR/>#9 MeSH descriptor Hemostasis, Surgical explode all trees<BR/>#10 MeSH descriptor Hemostasis explode all trees<BR/>#11 "blood loss" OR "blood losses" OR hemorrhage OR hemorrhages OR haemorrhage OR haemorrhages OR hemostasis OR hemostases OR haemostasis OR haemostases<BR/>#12 (#8 OR #9 OR #10 OR #11)<BR/>#13 (#7 AND #12)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MEDLINE (PubMed)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1950 to March 2008</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>((("Liver"[MeSH] OR liver OR hepatic) AND (segmentectomy OR resection OR transection)) OR "Hepatectomy"[MeSH]) AND ("Hemorrhage"[MeSH] OR "Hemostasis, Surgical"[MeSH] OR "Hemostasis"[MeSH] OR "blood loss" OR "blood losses" OR hemorrhage OR hemorrhages OR haemorrhage OR haemorrhages OR hemostasis OR hemostases OR haemostasis OR haemostases) AND ((randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo [tiab] OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab]) AND humans [mh])</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>EMBASE (Dialog Datastar)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1980 to March 2008</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 Bleeding#.W..DE. OR blood ADJ loss OR blood ADJ losses OR hemorrhage OR hemorrhages OR haemorrhage OR haemorrhages OR hemostasis OR hemostases OR haemostasis OR haemostases<BR/>2 LIVER OR HEPATIC OR HEPATO<BR/>3 SEGMENTECTOMY OR RESECTION<BR/>4 2 AND 3<BR/>5 HEPATECTOMY OR LIVER-RESECTION.DE.<BR/>6 4 OR 5<BR/>7 1 AND 6<BR/>8 RANDOM$ OR FACTORIAL$ OR CROSSOVER$ OR CROSS ADJ OVER$ OR PLACEBO$ OR DOUBL$ ADJ BLIND$ OR SINGL$ ADJ BLIND$ OR ASSIGN$ OR ALLOCAT$ OR VOLUNTEER$ OR CROSSOVER-PROCEDURE#.MJ. OR DOUBLE-BLIND-PROCEDURE#.DE. OR SINGLE-BLIND-PROCEDURE#.DE. OR RANDOMIZED-CONTROLLED-TRIAL#.DE.<BR/>9 7 AND 8</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Science Citation Index Expanded (http://portal.isiknowledge.com/portal.cgi?DestApp=WOS&amp;Func=Frame)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1970 to March 2008</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 TS=(liver or hepatic)<BR/>#2 TS=(segmentectomy OR resection OR transection)<BR/>#3 #2 AND #1<BR/>#4 TS=(hepatectomy)<BR/>#5 #4 OR #3<BR/>#6 TS=("blood loss" OR "blood losses" OR hemorrhage OR hemorrhages OR haemorrhage OR haemorrhages OR hemostasis OR hemostases OR haemostasis OR haemostases)<BR/>#7 TS=(random* OR blind* OR placebo* OR meta-analysis)<BR/>#8 #7 AND #6 AND #5</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>